Recent advances in hepatitis E virus research and the Japanese clinical practice guidelines for hepatitis E virus infection.

Balayan MS, Andjaparidze AG, Savinskaya SS, Ketiladze ES, Braginsky DM, Savinov AP, et al. Evidence for a virus in non‐A, non‐B hepatitis transmitted via the fecal‐oral route. Intervirology. 1983;20(1):23–31. PMID: 6409836. https://doi.org/10.1159/000149370

Bradley DW, Krawczynski K, Cook EH, Jr, McCaustland KA, Humphrey CD, Spelbring JE, et al. Enterically transmitted non‐A, non‐B hepatitis: serial passage of disease in cynomolgus macaques and tamarins and recovery of disease‐associated 27‐ to 34‐nm viruslike particles. Proc Natl Acad Sci U S A. 1987;84(17):6277–6281. PMID: 3114746. https://doi.org/10.1073/pnas.84.17.6277

Reyes GR, Purdy MA, Kim JP, Luk KC, Young LM, Fry KE, et al. Isolation of a cDNA from the virus responsible for enterically transmitted non‐A, non‐B hepatitis. Science. 1990;247(4948):1335–1339. PMID: 2107574. https://doi.org/10.1126/science.2107574

Ray R, Aggarwal R, Salunke PN, Mehrotra NN, Talwar GP, Naik SR. Hepatitis E virus genome in stools of hepatitis patients during large epidemic in north India. Lancet. 1991;338(8770):783–784. PMID: 1681163. https://doi.org/10.1016/0140‐6736(91)90667‐e

Khuroo MS, Khuroo MS. Seroepidemiology of a second epidemic of hepatitis E in a population that had recorded first epidemic 30 years before and has been under surveillance since then. Hepatol Int. 2010;4(2):494–499. PMID: 20827406. https://doi.org/10.1007/s12072‐009‐9159‐5

Huang CC, Nguyen D, Fernandez J, Yun KY, Fry KE, Bradley DW, et al. Molecular cloning and sequencing of the Mexico isolate of hepatitis E virus (HEV). Virology. 1992;191(2):550–558. PMID: 1448913. https://doi.org/10.1016/0042‐6822(92)90230‐m

Skaug K, Hagen IJ, von der Lippe B. Hepatitis E‐‐an important cause of imported non‐A, non‐B hepatitis among migrant workers in Qatar. Scand J Infect Dis. 1994;26(2):137–139. PMID: 8036468. https://doi.org/10.3109/00365549409011776

Kwo PY, Schlauder GG, Carpenter HA, Murphy PJ, Rosenblatt JE, Dawson GJ, et al. Acute hepatitis E by a new isolate acquired in the United States. Mayo Clin Proc. 1997;72(12):1133–1136. PMID: 9413292. https://doi.org/10.4065/72.12.1133

Schlauder GG, Dawson GJ, Erker JC, Kwo PY, Knigge MF, Smalley DL, et al. The sequence and phylogenetic analysis of a novel hepatitis E virus isolated from a patient with acute hepatitis reported in the United States. J Gen Virol. 1998;79(Pt 3):447–456. PMID: 9519822. https://doi.org/10.1099/0022‐1317‐79‐3‐447

Meng XJ, Halbur PG, Shapiro MS, Govindarajan S, Bruna JD, Mushahwar IK, et al. Genetic and experimental evidence for cross‐species infection by swine hepatitis E virus. J Virol. 1998;72(12):9714–9721. PMID: 9811705. https://doi.org/10.1128/JVI.72.12.9714‐9721.1998

Wang Y, Zhang H, Ling R, Li H, Harrison TJ. The complete sequence of hepatitis E virus genotype 4 reveals an alternative strategy for translation of open reading frames 2 and 3. J Gen Virol. 2000;81(Pt 7):1675–1686. PMID: 10859372. https://doi.org/10.1099/0022‐1317‐81‐7‐1675

Takahashi K, Iwata K, Watanabe N, Hatahara T, Ohta Y, Baba K, et al. Full‐genome nucleotide sequence of a hepatitis E virus strain that may be indigenous to Japan. Virology. 2001;287(1):9–12. PMID: 11504536. https://doi.org/10.1006/viro.2001.1017

Okamoto H, Takahashi M, Nishizawa T, Fukai K, Muramatsu U, Yoshikawa A. Analysis of the complete genome of indigenous swine hepatitis E virus isolated in Japan. Biochem Biophys Res Commun. 2001;289(5):929–936. PMID: 11741279. https://doi.org/10.1006/bbrc.2001.6088

Worm HC, Schlauder GG, Brandstätter G. Hepatitis E and its emergence in non‐endemic areas. Wien Klin Wochenschr. 2002;114(15‐16):663–670. PMID: 12602109.

Takahashi M, Nishizawa T, Miyajima H, Gotanda Y, Iita T, Tsuda F, et al. Swine hepatitis E virus strains in Japan form four phylogenetic clusters comparable with those of Japanese isolates of human hepatitis E virus. J Gen Virol. 2003;84(Pt 4):851–862. PMID: 12655086. https://doi.org/10.1099/vir.0.18918‐0

Takahashi K, Kang JH, Ohnishi S, Hino K, Mishiro S. Genetic heterogeneity of hepatitis E virus recovered from Japanese patients with acute sporadic hepatitis. J Infect Dis. 2002;185(9):1342–1345. PMID: 12001054. https://doi.org/10.1086/340023

Takahashi M, Nishizawa T, Yoshikawa A, Sato S, Isoda N, Ido K, et al. Identification of two distinct genotypes of hepatitis E virus in a Japanese patient with acute hepatitis who had not travelled abroad. J Gen Virol. 2002;83(Pt 8):1931–1940. PMID: 12124457. https://doi.org/10.1099/0022‐1317‐83‐8‐1931

Mizuo H, Suzuki K, Takikawa Y, Sugai Y, Tokita H, Akahane Y, et al. Polyphyletic strains of hepatitis E virus are responsible for sporadic cases of acute hepatitis in Japan. J Clin Microbiol. 2002;40(9):3209–3218. PMID: 12202555. https://doi.org/10.1128/JCM.40.9.3209‐3218.2002

Sugiyama R, Takahara O, Yahata Y, Kanou K, Nagashima M, Kiyohara T, et al. Nationwide epidemiologic and genetic surveillance of hepatitis E in Japan, 2014‐2021. J Med Virol. 2023;95(6):e28886. PMID: 37350032. https://doi.org/10.1002/jmv.28886

Nishizawa T, Takahashi M, Mizuo H, Miyajima H, Gotanda Y, Okamoto H. Characterization of Japanese swine and human hepatitis E virus isolates of genotype IV with 99 % identity over the entire genome. J Gen Virol. 2003;84(Pt 5):1245–1251. PMID: 12692290. https://doi.org/10.1099/vir.0.19052‐0

Ohnishi S, Kang JH, Maekubo H, Takahashi K, Mishiro S. A case report: two patients with fulminant hepatitis E in Hokkaido, Japan. Hepatol Res. 2003;25(2):213–218. PMID: 12644058. https://doi.org/10.1016/s1386‐6346(03)00009‐3

Kuno A, Ido K, Isoda N, Satoh Y, Ono K, Satoh S, et al. Sporadic acute hepatitis E of a 47‐year‐old man whose pet cat was positive for antibody to hepatitis E virus. Hepatol Res. 2003;26(3):237–242. PMID: 12850697. https://doi.org/10.1016/s1386‐6346(03)00197‐9

Yazaki Y, Mizuo H, Takahashi M, Nishizawa T, Sasaki N, Gotanda Y, et al. Sporadic acute or fulminant hepatitis E in Hokkaido, Japan, may be food‐borne, as suggested by the presence of hepatitis E virus in pig liver as food. J Gen Virol. 2003;84(Pt 9):2351–2357. PMID: 12917455. https://doi.org/10.1099/vir.0.19242‐0

Suzuki K, Aikawa T, Okamoto H. Fulminant hepatitis E in Japan. N Engl J Med. 2002;347(18):1456. PMID: 12409557. https://doi.org/10.1056/NEJM200210313471819

Sonoda H, Abe M, Sugimoto T, Sato Y, Bando M, Fukui E, et al. Prevalence of hepatitis E virus (HEV) Infection in wild boars and deer and genetic identification of a genotype 3 HEV from a boar in Japan. J Clin Microbiol. 2004;42(11):5371–5374. PMID: 15528746. https://doi.org/10.1128/JCM.42.11.5371‐5374.2004

Tei S, Kitajima N, Takahashi K, Mishiro S. Zoonotic transmission of hepatitis E virus from deer to human beings. Lancet. 2003;362(9381):371–373. PMID: 12907011. https://doi.org/10.1016/S0140‐6736(03)14025‐1

Tei S, Kitajima N, Ohara S, Inoue Y, Miki M, Yamatani T, et al. Consumption of uncooked deer meat as a risk factor for hepatitis E virus infection: an age‐ and sex‐matched case‐control study. J Med Virol. 2004;74(1):67–70. PMID: 15258970. https://doi.org/10.1002/jmv.20147

Nishizawa T, Takahashi M, Endo K, Fujiwara S, Sakuma N, Kawazuma F, et al. Analysis of the full‐length genome of hepatitis E virus isolates obtained from wild boars in Japan. J Gen Virol. 2005;86(Pt 12):3321–3326. PMID: 16298977. https://doi.org/10.1099/vir.0.81394‐0

Li TC, Chijiwa K, Sera N, Ishibashi T, Etoh Y, Shinohara Y, et al. Hepatitis E virus transmission from wild boar meat. Emerg Infect Dis. 2005;11(12):1958–1960. PMID: 16485490. https://doi.org/10.3201/eid1112.051041

Takahashi K, Kitajima N, Abe N, Mishiro S. Complete or near‐complete nucleotide sequences of hepatitis E virus genome recovered from a wild boar, a deer, and four patients who ate the deer. Virology. 2004;330(2):501–505. PMID: 15567444. https://doi.org/10.1016/j.virol.2004.10.006

Wibawa ID, Muljono DH, Mulyanto, Suryadarma IG, Tsuda F, Takahashi M, et al. Prevalence of antibodies to hepatitis E virus among apparently healthy humans and pigs in Bali, Indonesia: identification of a pig infected with a genotype 4 hepatitis E virus. J Med Virol. 2004;73(1):38–44. PMID: 15042646. https://doi.org/10.1002/jmv.20059

Aikawa T, Kojima M, Takahashi M, Nishizawa T, Okamoto H. Identification of indigenous hepatitis E virus from a Japanese patient who contracted sporadic acute hepatitis in 1982. J Infect Dis. 2002;186(10):1535–1536. PMID: 12404177 author reply 1536–7. https://doi.org/10.1086/344349

Mitsui T, Tsukamoto Y, Yamazaki C, Masuko K, Tsuda F, Takahashi M, et al. Prevalence of hepatitis E virus infection among hemodialysis patients in Japan: evidence for infection with a genotype 3 HEV by blood transfusion. J Med Virol. 2004;74(4):563–572. PMID: 15484278. https://doi.org/10.1002/jmv.20215

Takahashi M, Nishizawa T, Okamoto H. Identification of a genotype III swine hepatitis E virus that was isolated from a Japanese pig born in 1990 and that is most closely related to Japanese isolates of human hepatitis E virus. J Clin Microbiol. 2003;41(3):1342–1343. PMID: 12624083. https://doi.org/10.1128/JCM.41.3.1342‐1343.2003

Tokita H, Harada H, Gotanda Y, Takahashi M, Nishizawa T, Okamoto H. Molecular and serological characterization of sporadic acute hepatitis E in a Japanese patient infected with a genotype III hepatitis E virus in 1993. J Gen Virol. 2003;84(Pt 2):421–427. PMID: 12560575. https://doi.org/10.1099/vir.0.18802‐0

Tanaka Y, Takahashi K, Orito E, Karino Y, Kang JH, Suzuki K, et al. Molecular tracing of Japan‐indigenous hepatitis E viruses. J Gen Virol. 2006;87(Pt 4):949–954. PMID: 16528044. https://doi.org/10.1099/vir.0.81661‐0

Nakano T, Takahashi K, Pybus OG, Hashimoto N, Kato H, Okano H, et al. New findings regarding the epidemic history and population dynamics of Japan‐indigenous genotype 3 hepatitis E virus inferred by molecular evolution. Liver Int. 2012;32(4):675–688. PMID: 22181032. https://doi.org/10.1111/j.1478‐3231.2011.02728.x

Dalton HR, Webb GW, Norton BC, Woolson KL. Hepatitis E virus: Time to change the textbooks. Dig Dis. 2016;34(4):308–316. PMID: 27170383. https://doi.org/10.1159/000444468

Takahashi M, Kusakai S, Mizuo H, Suzuki K, Fujimura K, Masuko K, et al. Simultaneous detection of immunoglobulin A (IgA) and IgM antibodies against hepatitis E virus (HEV) Is highly specific for diagnosis of acute HEV infection. J Clin Microbiol. 2005;43(1):49–56. PMID: 15634950. https://doi.org/10.1128/JCM.43.1.49‐56.2005

Takahashi M, Okamoto H. Features of hepatitis E virus infection in humans and animals in Japan. Hepatol Res. 2014;44(1):43–58. PMID: 23721425. https://doi.org/10.1111/hepr.12175

Satake M, Matsubayashi K, Hoshi Y, Taira R, Furui Y, Kokudo N, et al. Unique clinical courses of transfusion‐transmitted hepatitis E in patients with immunosuppression. Transfusion. 2017;57(2):280–288. PMID: 28144952. https://doi.org/10.1111/trf.13994

Matsubayashi K, Nagaoka Y, Sakata H, Sato S, Fukai K, Kato T, et al. Transfusion‐transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan. Transfusion. 2004;44(6):934–940. PMID: 15157263. https://doi.org/10.1111/j.1537‐2995.2004.03300.x

Sakata H, Matsubayashi K, Iida J, Nakauchi K, Kishimoto S, Sato S, et al. Trends in hepatitis E virus infection: analyses of the long‐term screening of blood donors in Hokkaido, Japan, 2005‐2019. Transfusion. 2021;61(12):3390–3401. PMID: 34632593. https://doi.org/10.1111/trf.16700

Tanaka A, Matsubayashi K, Odajima T, Sakata H, Iida J, Kai K, et al. Universal nucleic acid donor screening revealed epidemiological features of hepatitis E and prevented transfusion‐transmitted infection in Japan. Transfusion. 2024;64(2):335–347. PMID: 38152964. https://doi.org/10.1111/trf.17696

Takahashi M, Tamura K, Hoshino Y, Nagashima S, Yazaki Y, Mizuo H, et al. A nationwide survey of hepatitis E virus infection in the general population of Japan. J Med Virol. 2010;82(2):271–281. PMID: 20029817. https://doi.org/10.1002/jmv.21678

Yamazaki Y, Naganuma A, Arai Y, Takeuchi S, Kobayashi T, Takakusagi S, et al. Clinical and virological features of acute hepatitis E in Gunma prefecture, Japan between 2004 and 2015. Hepatol Res. 2017;47(5):435–445. PMID: 27322051. https://doi.org/10.1111/hepr.12765

Sato N, Watanabe S, Miura K, Morimoto N, Takaoka Y, Nomoto H, et al. Clinical and virologic features of hepatitis E virus infection at a university hospital in Japan between 2000 and 2019. J Med Virol. 2020;92(12):3572–3583. PMID: 32609895. https://doi.org/10.1002/jmv.26248

Yoshida Y, Ito A, Eto H, Suzuki A, Abe T, Endo K, et al. Seroprevalence and incidence of hepatitis E virus infection in the general population of Iwate prefecture, Japan: a retrospective cohort study. Hepatol Res. 2024;54(1):24–31. PMID: 37635642. https://doi.org/10.1111/hepr.13961

Nakano T, Okano H, Kobayashi M, Ito K, Ohmori S, Nomura T, et al. Molecular epidemiology and genetic history of European‐type genotype 3 hepatitis E virus indigenized in the central region of Japan. Infect Genet Evol. 2012;12(7):1524–1534. PMID: 22706162. https://doi.org/10.1016/j.meegid.2012.06.002

Nakano T, Takahashi M, Takahashi K, Nagashima S, Suzuki Y, Nishigaki Y, et al. Hepatitis E virus subtype 3f strains isolated from Japanese hepatitis patients with no history of travel to endemic areas ‐ the origin analyzed by molecular evolution. Virology. 2018;513:146–152. PMID: 29078116. https://doi.org/10.1016/j.virol.2017.08.008

Nakano T, Okano H, Takahashi M, Nagashima S, Shiraki K, Oya Y, et al. Changing clinical and molecular characteristics of hepatitis E virus infection in Mie Prefecture, Japan: Disappearance of indigenous subtype 3e strains. Hepatol Res. 2019;49(9):1003–1014. PMID: 31026368. https://doi.org/10.1111/hepr.13357

Takeda H, Matsubayashi K, Sakata H, Sato S, Kato T, Hino S, et al. A nationwide survey for prevalence of hepatitis E virus antibody in qualified blood donors in Japan. Vox Sang. 2010;99(4):307–313. PMID: 20576022. https://doi.org/10.1111/j.1423‐0410.2010.01362.x

Takahashi M, Kunita S, Nishizawa T, Ohnishi H, Primadharsini PP, Nagashima S, et al. Infection dynamics and genomic mutations of hepatitis E virus in naturally infected pigs on a farrow‐to‐finish farm in Japan: a survey from 2012 to 2021. Viruses. 2023;15(7):1516. PMID: 37515202. https://doi.org/10.3390/v15071516

Mendoza MV, Yonemitsu K, Ishijima K, Kuroda Y, Tatemoto K, Inoue Y, et al. Nationwide survey of hepatitis E virus infection among wildlife in Japan. J Vet Med Sci. 2022;84(7):992–1000. PMID: 35675975. https://doi.org/10.1292/jvms.22‐0237

Fukuda S, Sunaga J, Saito N, Fujimura K, Itoh Y, Sasaki M, et al. Prevalence of antibodies to hepatitis E virus among Japanese blood donors: identification of three blood donors infected with a genotype 3 hepatitis E virus. J Med Virol. 2004;73(4):554–561. PMID: 15221899. https://doi.org/10.1002/jmv.20125

Baylis SA, Hanschmann KO, Matsubayashi K, Sakata H, Roque‐Afonso AM, Kaiser M, et al. Development of a World Health Organization International Reference Panel for different genotypes of hepatitis E virus for nucleic acid amplification testing. J Clin Virol. 2019;119:60–67. PMID: 31431408. https://doi.org/10.1016/j.jcv.2019.05.006

Matsui T, Kang JH, Matsubayashi K, Yamazaki H, Nagai K, Sakata H, et al. Rare case of transfusion‐transmitted hepatitis E from the blood of a donor infected with the hepatitis E virus genotype 3 indigenous to Japan: viral dynamics from onset to recovery. Hepatol Res. 2015;45(6):698–704. PMID: 25041213. https://doi.org/10.1111/hepr.12390

Kikuchi K, Yoshida T, Kimata N, Sato C, Akiba T. Prevalence of hepatitis E virus infection in regular hemodialysis patients. Ther Apher Dial. 2006;10(2):193–197. PMID: 16684223. https://doi.org/10.1111/j.1744‐9987.2006.00363.x

Toyoda H, Honda T, Hayashi K, Katano Y, Goto H, Kumada T, et al. Prevalence of hepatitis E virus IgG antibody in Japanese patients with hemophilia. Intervirology. 2008;51(1):21–25. PMID: 18309245. https://doi.org/10.1159/000118792

Kurihara T, Yoshizumi T, Itoh S, Harimoto N, Harada N, Ikegami T, et al. Chronic hepatitis E virus infection after living donor liver transplantation via blood transfusion: a case report. Surg Case Rep. 2016;2(1):32. PMID: 27059470. https://doi.org/10.1186/s40792‐016‐0159‐0

Inagaki Y, Oshiro Y, Tanaka T, Yoshizumi T, Okajima H, Ishiyama K, et al. A Nationwide survey of hepatitis E virus infection and chronic hepatitis E in liver transplant recipients in Japan. EBioMedicine. 2015;2(11):1607–1612. PMID: 26870785. https://doi.org/10.1016/j.ebiom.2015.09.030

Navaneethan U, Al MM, Shata MT. Hepatitis E and pregnancy: understanding the pathogenesis. Liver Int. 2008;28(9):1190–1199. PMID: 18662274. https://doi.org/10.1111/j.1478‐3231.2008.01840.x

Anty R, Ollier L, Péron JM, Nicand E, Cannavo I, Bongain A, et al. First case report of an acute genotype 3 hepatitis E infected pregnant woman living in South‐Eastern France. J Clin Virol. 2012;54(1):76–78. PMID: 22336086. https://doi.org/10.1016/j.jcv.2012.01.016

Tabatabai J, Wenzel JJ, Soboletzki M, Flux C, Navid MH, Schnitzler P. First case report of an acute hepatitis E subgenotype 3c infection during pregnancy in Germany. J Clin Virol. 2014;61(1):170–172. PMID: 24996764. https://doi.org/10.1016/j.jcv.2014.06.008

Dalton HR, Izopet J. Transmission and epidemiology of hepatitis E virus genotype 3 and 4 infections. Cold Spring Harb Perspect Med. 2018;8(11):a032144. PMID: 29530946. https://doi.org/10.1101/cshperspect.a032144

Bouthry E, Benachi A, Vivanti AJ, Letamendia E, Vauloup‐Fellous C, Roque‐Afonso AM. Autochthonous hepatitis E during pregnancy, France. Emerg Infect Dis. 2018;24(8):1586–1587. PMID: 30016249. https://doi.org/10.3201/eid2408.180105

Nimgaonkar I, Ding Q, Schwartz RE, Ploss A. Hepatitis E virus: advances and challenges. Nat Rev Gastroenterol Hepatol. 2018;15(2):96–110. PMID: 29162935. https://doi.org/10.1038/nrgastro.2017.150

Huy PX, Chung DT, Linh DT, Hang NT, Rachakonda S, Pallerla SR, et al. Low prevalence of HEV infection and No associated risk of HEV transmission from mother to child among pregnant women in Vietnam. Pathogens. 2021;10(10):1340. PMID: 34684289. https://doi.org/10.3390/pathogens10101340

Goto K, Ito K, Sugiura T, Ando T, Mizutani F, Miyake Y, et al. Prevalence of hepatitis E virus infection in Japanese children. J Pediatr Gastroenterol Nutr. 2006;42(1):89–92. PMID: 16385260. https://doi.org/10.1097/01.mpg.0000188005.81999.32

Sanayama Y, Ishiwada N, Fukasawa C, Kanazawa M, Tamano Y, Yano K, et al. A pediatric patient with acute hepatitis E in Japan. J Infect Chemother. 2008;14(5):374–376. PMID: 18936892. https://doi.org/10.1007/s10156‐008‐0633‐0

Purdy MA, Drexler JF, Meng XJ, Norder H, Okamoto H, Van der Poel WHM, et al. ICTV virus taxonomy profile: hepeviridae 2022. J Gen Virol. 2022;103(9). PMID: 36170152. https://doi.org/10.1099/jgv.0.001778

Primadharsini PP, Nagashima S, Okamoto H. Genetic variability and evolution of hepatitis E virus. Viruses. 2019;11(5):456. PMID: 31109076. https://doi.org/10.3390/v11050456

Smith DB, Izopet J, Nicot F, Simmonds P, Jameel S, Meng XJ, et al. Update: proposed reference sequences for subtypes of hepatitis E virus (species Orthohepevirus A). J Gen Virol. 2020;101(7):692–698. PMID: 32469300. https://doi.org/10.1099/jgv.0.001435

Nishizawa T, Takahashi M, Tsatsralt‐Od B, Nyamdavaa K, Dulmaa N, Osorjin B, et al. Identification and a full genome analysis of novel camel hepatitis E virus strains obtained from Bactrian camels in Mongolia. Virus Res. 2021;299:198355. PMID: 33662492. https://doi.org/10.1016/j.virusres.2021.198355

Inoue J, Takahashi M, Ito K, Shimosegawa T, Okamoto H. Analysis of human and swine hepatitis E virus (HEV) isolates of genotype 3 in Japan that are only 81‐83 % similar to reported HEV isolates of the same genotype over the entire genome. J Gen Virol. 2006;87(Pt 8):2363–2369. PMID: 16847132. https://doi.org/10.1099/vir.0.81912‐0

Matsubayashi K, Kang JH, Sakata H, Takahashi K, Shindo M, Kato M, et al. A case of transfusion‐transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food‐borne route. Transfusion. 2008;48(7):1368–1375. PMID: 18651907. https://doi.org/10.1111/j.1537‐2995.2008.01722.x

Kanai Y, Tsujikawa M, Yunoki M, Nishiyama S, Ikuta K, Hagiwara K. Long‐term shedding of hepatitis E virus in the feces of pigs infected naturally, born to sows with and without maternal antibodies. J Med Virol. 2010;82(1):69–76. PMID: 19950246. https://doi.org/10.1002/jmv.21647

Okano H, Takahashi M, Isono Y, Tanaka H, Nakano T, Oya Y, et al. Characterization of sporadic acute hepatitis E and comparison of hepatitis E virus genomes in acute hepatitis patients and pig liver sold as food in Mie, Japan. Hepatol Res. 2014;44(10):E63–E76. PMID: 23927634. https://doi.org/10.1111/hepr.12216

Sato Y, Sato H, Naka K, Furuya S, Tsukiji H, Kitagawa K, et al. A nationwide survey of hepatitis E virus (HEV) infection in wild boars in Japan: identification of boar HEV strains of genotypes 3 and 4 and unrecognized genotypes. Arch Virol. 2011;156(8):1345–1358. PMID: 21475985. https://doi.org/10.1007/s00705‐011‐0988‐x

Takahashi M, Nishizono A, Kawakami M, Fukui E, Isogai E, Matsuoka H, et al. Identification of hepatitis E virus in wild sika deer in Japan. Virus Res. 2022;308:198645. PMID: 34822952. https://doi.org/10.1016/j.virusres.2021.198645

Nakamura M, Takahashi K, Taira K, Taira M, Ohno A, Sakugawa H, et al. Hepatitis E virus infection in wild mongooses of Okinawa, Japan: demonstration of anti‐HEV antibodies and a full‐genome nucleotide sequence. Hepatol Res. 2006;34(3):137–140. PMID: 16413822. https://doi.org/10.1016/j.hepres.2005.10.010

Mendoza MV, Yonemitsu K, Ishijima K, Minami S, Supriyono, Tran NTB, et al. Characterization of rabbit hepatitis E virus isolated from a feral rabbit. Vet Microbiol. 2021;263:109275. PMID: 34798367. https://doi.org/10.1016/j.vetmic.2021.109275

Yamamoto H, Suzuki J, Matsuda A, Ishida T, Ami Y, Suzaki Y, et al. Hepatitis E virus outbreak in monkey facility, Japan. Emerg Infect Dis. 2012;18(12):2032–2034. PMID: 23171579. https://doi.org/10.3201/eid1812.120884

Miyashita K, Kang JH, Saga A, Takahashi K, Shimamura T, Yasumoto A, et al. Three cases of acute or fulminant hepatitis E caused by ingestion of pork meat and entrails in Hokkaido, Japan: zoonotic food‐borne transmission of hepatitis E virus and public health concerns. Hepatol Res. 2012;42(9):870–878. PMID: 22568494. https://doi.org/10.1111/j.1872‐034X.2012.01006.x

Koizumi Y, Isoda N, Sato Y, Iwaki T, Ono K, Ido K, et al. Infection of a Japanese patient by genotype 4 hepatitis E virus while traveling in Vietnam. J Clin Microbiol. 2004;42(8):3883–3885. PMID: 15297556. https://doi.org/10.1128/JCM.42.8.3883‐3885.2004

Li TC, Miyamura T, Takeda N. Detection of hepatitis E virus RNA from the bivalve Yamato‐Shijimi (Corbicula japonica) in Japan. Am J Trop Med Hyg. 2007;76(1):170–172. PMID: 17255247. https://doi.org/10.4269/ajtmh.2007.76.170

Crossan C, Baker PJ, Craft J, Takeuchi Y, Dalton HR, Scobie L. Hepatitis E virus genotype 3 in shellfish, United Kingdom. Emerg Infect Dis. 2012;18(12):2085–2087. PMID: 23171845. https://doi.org/10.3201/eid1812.120924

La RG, Proroga YTR, De Medici D, Capuano F, Iaconelli M, Della LS, et al. First detection of hepatitis E virus in shellfish and in seawater from production areas in Southern Italy. Food Environ Virol. 2018;10(1):127–131. PMID: 28956272. https://doi.org/10.1007/s12560‐017‐9319‐z

Rivadulla E, Varela MF, Mesquita JR, Nascimento MSJ, Romalde JL. Detection of hepatitis E virus in shellfish harvesting areas from Galicia (Northwestern Spain). Viruses. 2019;11(7):618. PMID: 31284466. https://doi.org/10.3390/v11070618

Kamar N, Selves J, Mansuy JM, Ouezzani L, Péron JM, Guitard J, et al. Hepatitis E virus and chronic hepatitis in organ‐transplant recipients. N Engl J Med. 2008;358(8):811–817. PMID: 18287603. https://doi.org/10.1056/NEJMoa0706992

Owada Y, Oshiro Y, Inagaki Y, Harada H, Fujiyama N, Kawagishi N, et al. A nationwide survey of hepatitis E virus infection and chronic hepatitis in heart and kidney transplant recipients in Japan. Transplantation. 2020;104(2):437–444. PMID: 31205267. https://doi.org/10.1097/TP.0000000000002801

Tam AW, Smith MM, Guerra ME, Huang CC, Bradley DW, Fry KE, et al. Hepatitis E virus (HEV): molecular cloning and sequencing of the full‐length viral genome. Virology. 1991;185(1):120–131. PMID: 1926770. https://doi.org/10.1016/0042‐6822(91)90760‐9

Kenney SP, Meng XJ. Hepatitis E virus genome structure and replication strategy. Cold Spring Harb Perspect Med. 2019;9(1):a031724. PMID: 29530948. https://doi.org/10.1101/cshperspect.a031724

Graff J, Torian U, Nguyen H, Emerson SU. A bicistronic subgenomic mRNA encodes both the ORF2 and ORF3 proteins of hepatitis E virus. J Virol. 2006;80(12):5919–5926. PMID: 16731930. https://doi.org/10.1128/JVI.00046‐06

Montpellier C, Wychowski C, Sayed IM, Meunier JC, Saliou JM, Ankavay M, et al. Hepatitis E virus lifecycle and identification of 3 forms of the ORF2 capsid protein. Gastroenterology. 2018;154(1):211–223.e8. PMID: 28958858. https://doi.org/10.1053/j.gastro.2017.09.020

Yin X, Ying D, Lhomme S, Tang Z, Walker CM, Xia N, et al. Origin, antigenicity, and function of a secreted form of ORF2 in hepatitis E virus infection. Proc Natl Acad Sci USA. 2018;115(18):4773–4778. PMID: 29669922. https://doi.org/10.1073/pnas.1721345115

Kalia M, Chandra V, Rahman SA, Sehgal D, Jameel S. Heparan sulfate proteoglycans are required for cellular binding of the hepatitis E virus ORF2 capsid protein and for viral infection. J Virol. 2009;83(24):12714–12724. PMID: 19812150. https://doi.org/10.1128/JVI.00717‐09

Reyes GR, Huang CC, Tam AW, Purdy MA. Molecular organization and replication of hepatitis E virus (HEV). Arch Virol Suppl. 1993;7:15–25. PMID: 8219799. https://doi.org/10.1007/978‐3‐7091‐9300‐6_2

Xing L, Wang JC, Li TC, Yasutomi Y, Lara J, Khudyakov Y, et al. Spatial configuration of hepatitis E virus antigenic domain. J Virol. 2011;85(2):1117–1124. PMID: 21068233. https://doi.org/10.1128/JVI.00657‐10

Chandra V, Taneja S, Kalia M, Jameel S. Molecular biology and pathogenesis of hepatitis E virus. J Biosci. 2008;33(4):451–464. PMID: 19208971. https://doi.org/10.1007/s12038‐008‐0064‐1

Yamada K, Takahashi M, Hoshino Y, Takahashi H, Ichiyama K, Nagashima S, et al. ORF3 protein of hepatitis E virus is essential for virion release from infected cells. J Gen Virol. 2009;90(Pt 8):1880–1891. PMID: 19339479. https://doi.org/10.1099/vir.0.010561‐0

Emerson SU, Nguyen HT, Torian U, Burke D, Engle R, Purcell RH. Release of genotype 1 hepatitis E virus from cultured hepatoma and polarized intestinal cells depends on open reading frame 3 protein and requires an intact PXXP motif. J Virol. 2010;84(18):9059–9069. PMID: 20610720. https://doi.org/10.1128/JVI.00593‐10

Nagashima S, Takahashi M, Jirintai, Tanaka T, Yamada K, Nishizawa T, et al. A PSAP motif in the ORF3 protein of hepatitis E virus is necessary for virion release from infected cells. J Gen Virol. 2011;92(Pt 2):269–278. PMID: 21068219. https://doi.org/10.1099/vir.0.025791‐0

Ding Q, Heller B, Capuccino JM, Song B, Nimgaonkar I, Hrebikova G, et al. Hepatitis E virus ORF3 is a functional ion channel required for release of infectious particles. Proc Natl Acad Sci USA. 2017;114(5):1147–1152. PMID: 28096411. https://doi.org/10.1073/pnas.1614955114

Primadharsini PP, Nagashima S, Nishiyama T, Okamoto H. Three distinct reporter systems of hepatitis E virus and their utility as drug screening platforms. Viruses. 2023;15(10):1989. PMID: 37896767. https://doi.org/10.3390/v15101989

Nagashima S, Takahashi M, Kobayashi T, Tanggis NT, Nishiyama T, Primadharsini PP, et al. Characterization of the quasi‐enveloped hepatitis E virus particles released by the cellular exosomal pathway. J Virol. 2017;91(22):e008222–17. PMID: 28878075. https://doi.org/10.1128/JVI.00822‐17

Takahashi M, Tanaka T, Takahashi H, Hoshino Y, Nagashima S, Jirintai, et al. Hepatitis E Virus (HEV) strains in serum samples can replicate efficiently in cultured cells despite the coexistence of HEV antibodies: characterization of HEV virions in blood circulation. J Clin Microbiol. 2010;48(4):1112–1125. PMID: 20107086. https://doi.org/10.1128/JCM.02002‐09

Takahashi M, Yamada K, Hoshino Y, Takahashi H, Ichiyama K, Tanaka T, et al. Monoclonal antibodies raised against the ORF3 protein of hepatitis E virus (HEV) can capture HEV particles in culture supernatant and serum but not those in feces. Arch Virol. 2008;153(9):1703–1713. PMID: 18679765. https://doi.org/10.1007/s00705‐008‐0179‐6

Okamoto H. Culture systems for hepatitis E virus. J Gastroenterol. 2013;48(2):147–158. PMID: 23104469. https://doi.org/10.1007/s00535‐012‐0682‐0

Wang B, Meng XJ. Structural and molecular biology of hepatitis E virus. Comput Struct Biotechnol J. 2021;19:1907–1916. PMID: 33995894. https://doi.org/10.1016/j.csbj.2021.03.038

Wißing MH, Brüggemann Y, Steinmann E, Todt D. Virus‐Host cell interplay during hepatitis E virus infection. Trends Microbiol. 2021;29(4):309–319. PMID: 3282864. https://doi.org/10.1016/j.tim.2020.07.002

Zhang L, Tian Y, Wen Z, Zhang F, Qi Y, Huang W, et al. Asialoglycoprotein receptor facilitates infection of PLC/PRF/5 cells by HEV through interaction with ORF2. J Med Virol. 2016;88(12):2186–2195. PMID: 27155063. https://doi.org/10.1002/jmv.24570

Shiota T, Li TC, Nishimura Y, Yoshizaki S, Sugiyama R, Shimojima M, et al. Integrin α3 is involved in non‐enveloped hepatitis E virus infection. Virology. 2019;536:119–124. PMID: 31421623. https://doi.org/10.1016/j.virol.2019.07.025

Zheng ZZ, Miao J, Zhao M, Tang M, Yeo AE, Yu H, et al. Role of heat‐shock protein 90 in hepatitis E virus capsid trafficking. J Gen Virol. 2010;91(Pt 7):1728–1736. PMID: 20219895. https://doi.org/10.1099/vir.0.019323‐0

Yin X, Li X, Feng Z. Role of envelopment in the HEV life cycle. Viruses. 2016;8(8):229. PMID: 27548201. https://doi.org/10.3390/v8080229

Yin X, Feng Z. Hepatitis E virus entry. Viruses. 2019;11(10):883. PMID: 31547135. https://doi.org/10.3390/v11100883

Schrader JA, Burkard TL, Brüggemann Y, Gömer A, Meister TL, Fu RM, et al. EGF receptor modulates HEV entry in human hepatocytes. Hepatology. 2023;77(6):2104–2117. PMID: 36745934. https://doi.org/10.1097/HEP.0000000000000308

Corneillie L, Lemmens I, Montpellier C, Ferrié M, Weening K, Van Houtte F, et al. The phosphatidylserine receptor TIM1 promotes infection of enveloped hepatitis E virus. Cell Mol Life Sci. 2023;80(11):326. PMID: 37833515. https://doi.org/10.1007/s00018‐023‐04977‐4

Yin X, Ambardekar C, Lu Y, Feng Z. Distinct entry mechanisms for nonenveloped and quasi‐enveloped hepatitis E viruses. J Virol. 2016;90(8):4232–4242. PMID: 26865708. https://doi.org/10.1128/JVI.02804‐15

Holla P, Ahmad I, Ahmed Z, Jameel S. Hepatitis E virus enters liver cells through a dynamin‐2, clathrin and membrane cholesterol‐dependent pathway. Traffic. 2015;16(4):398–416. PMID: 25615268. https://doi.org/10.1111/tra.12260

Himmelsbach K, Bender D, Hildt E. Life cycle and morphogenesis of the hepatitis E virus. Emerg Microb Infect. 2018;7(1):196. PMID: 30498191. https://doi.org/10.1038/s41426‐018‐0198‐7

Szkolnicka D, Pollán A, Da Silva N, Oechslin N, Gouttenoire J, Moradpour D. Recombinant hepatitis E viruses harboring tags in the ORF1 protein. J Virol. 2019;93(19):e00459–19. PMID: 31315997. https://doi.org/10.1128/JVI.00459‐19

LeDesma R, Heller B, Biswas A, Maya S, Gili S, Higgins J, et al. Structural features stabilized by divalent cation coordination within hepatitis E virus ORF1 are critical for viral replication. Elife. 2023;12:e80529. PMID: 3685290. https://doi.org/10.7554/eLife.80529

Paliwal D, Panda SK, Kapur N, Varma SPK, Durgapal H. Hepatitis E virus (HEV) protease: a chymotrypsin‐like enzyme that processes both non‐structural (pORF1) and capsid (pORF2) protein. J Gen Virol. 2014;95(Pt 8):1689–1700. PMID: 24795447. https://doi.org/10.1099/vir.0.066142‐0

Kanade GD, Pingale KD, Karpe YA. Activities of thrombin and factor xa are essential for replication of hepatitis E virus and are possibly implicated in ORF1 polyprotein processing. J Virol. 2018;92(6):e01853–17. PMID: 29321328. https://doi.org/10.1128/JVI.01853‐17

Pierce DM, Buchanan FJT, Macrae FL, Mills JT, Cox A, Abualsaoud KM, et al. Thrombin cleavage of the hepatitis E virus polyprotein at multiple conserved locations is required for genome replication. PLoS Pathog. 2023;19(7):e1011529. PMID: 37478143. https://doi.org/10.1371/journal.ppat.1011529

Nagashima S, Takahashi M, Jirintai S, Tanaka T, Nishizawa T, Yasuda J, et al. Tumour susceptibility gene 101 and the vacuolar protein sorting pathway are required for the release of hepatitis E virions. J Gen Virol. 2011;92(Pt 12):2838–2848. PMID: 21880841. https://doi.org/10.1099/vir.0.035378‐0

Nagashima S, Jirintai S, Takahashi M, Kobayashi T, Tanggis, Nishizawa T, et al. Hepatitis E virus egress depends on the exosomal pathway, with secretory exosomes derived from multivesicular bodies. J Gen Virol. 2014;95(Pt 10):2166–2175. PMID: 24970738. https://doi.org/10.1099/vir.0.066910‐0

Purcell RH, Emerson SU. Hepatitis E: an emerging awareness of an old disease. J Hepatol. 2008;48(3):494–503. PMID: 18192058. https://doi.org/10.1016/j.jhep.2007.12.008

Wedemeyer H, Pischke S, Manns MP. Pathogenesis and treatment of hepatitis e virus infection. Gastroenterology. 2012;142(6):1388–1397.e1. PMID: 22537448. https://doi.org/10.1053/j.gastro.2012.02.014

Buti M, Plans P, Domínguez A, Jardi R, Rodriguez Frias F, Esteban R, et al. Prevalence of hepatitis E virus infection in children in the northeast of Spain. Clin Vaccine Immunol. 2008;15(4):732–734. PMID: 18321881. https://doi.org/10.1128/CVI.00014‐08

Kamar N, Dalton HR, Abravanel F, Izopet J. Hepatitis E virus infection. Clin Microbiol Rev. 2014;27(1):116–138. PMID: 24396139. https://doi.org/10.1128/CMR.00057‐13

Acharya SK, Dasarathy S, Kumer TL, Sushma S, Prasanna KS, Tandon A, et al. Fulminant hepatitis in a tropical population: clinical course, cause, and early predictors of outcome. Hepatology. 1996;23(6):1448–1455. PMID: 8675163. https://doi.org/10.1002/hep.510230622

Hamid SS, Jafri SM, Khan H, Shah H, Abbas Z, Fields H. Fulminant hepatic failure in pregnant women: acute fatty liver or acute viral hepatitis? J Hepatol. 1996;25(1):20–27. PMID: 8836897. https://doi.org/10.1016/s0168‐8278(96)80323‐0

Hussaini SH, Skidmore SJ, Richardson P, Sherratt LM, Cooper BT, O'Grady JG. Severe hepatitis E infection during pregnancy. J Viral Hepat. 1997;4(1):51–54. PMID: 9031065. https://doi.org/10.1046/j.1365‐2893.1997.00123.x

Patra S, Kumar A, Trivedi SS, Puri M, Sarin SK. Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Ann Intern Med. 2007;147(1):28–33. PMID: 17606958. https://doi.org/10.7326/0003‐4819‐147‐1‐200707030‐00005

Borkakoti J, Hazam RK, Mohammad A, Kumar A, Kar P. Does high viral load of hepatitis E virus influence the severity and prognosis of acute liver failure during pregnancy? J Med Virol. 2013;85(4):620–626. PMID: 23280991. https://doi.org/10.1002/jmv.23508

Ratho RK, Thakur V, Arya S, Singh MP, Suri V, Das A. Placenta as a site of HEV replication and inflammatory cytokines modulating the immunopathogenesis of HEV in pregnant women. J Med Virol. 2022;94(7):3457–3463. PMID: 35257382. https://doi.org/10.1002/jmv.27699

Takahashi M, Tanaka T, Azuma M, Kusano E, Aikawa T, Shibayama T, et al. Prolonged fecal shedding of hepatitis E virus (HEV) during sporadic acute hepatitis E: evaluation of infectivity of HEV in fecal specimens in a cell culture system. J Clin Microbiol. 2007;45(11):3671–3679. PMID: 17728471. https://doi.org/10.1128/JCM.01086‐07

Hino K, Kondo T, Niwa H, Uchida T, Shikata T, Rikahisa T, et al. A small epidemic of enterically transmitted non‐A, non‐B acute hepatitis. Gastroenterol Jpn. 1991;26(Suppl 3):139–141. PMID: 1909253. https://doi.org/10.1007/BF02779284

Ishikawa K, Matsui K, Madarame T, Sato S, Oikawa K, Uchida T. Hepatitis E probably contracted via a Chinese herbal medicine, demonstrated by nucleotide sequencing. J Gastroenterol. 1995;30(4):534–538. PMID: 7550868. https://doi.org/10.1007/BF02347574

Okamoto H, Takahashi M, Nishizawa T. Features of hepatitis E virus infection in Japan. Intern Med. 2003;42(11):1065–1071. PMID: 14686743. https://doi.org/10.2169/internalmedicine.42.1065

Chauhan A, Jameel S, Dilawari JB, Chawla YK, Kaur U, Ganguly NK. Hepatitis E virus transmission to a volunteer. Lancet. 1993;341(8838):149–150. PMID: 8093748. https://doi.org/10.1016/0140‐6736(93)90008‐5

Borgen K, Herremans T, Duizer E, Vennema H, Rutjes S, Bosman A, et al. Non‐travel related Hepatitis E virus genotype 3 infections in The Netherlands; a case series 2004 ‐ 2006. BMC Infect Dis. 2008;8(1):61. PMID: 18462508. https://doi.org/10.1186/1471‐2334‐8‐61

Sainokami S, Abe K, Kumagai I, Miyasaka A, Endo R, Takikawa Y, et al. Epidemiological and clinical study of sporadic acute hepatitis E caused by indigenous strains of hepatitis E virus in Japan compared with acute hepatitis A. J Gastroenterol. 2004;39(7):640–648. PMID: 15293134. https://doi.org/10.1007/s00535‐003‐1359‐5

National Institute of Infectious Diseases. (in Japanese). 2017. https://www.niid.go.jp/niid/images/lab‐manual/HEV181207.pdf. Accessed on 5 February 2024.3

Miyahara K, Miyake Y, Yasunaka T, Ikeda F, Takaki A, Iwasaki Y, et al. Acute hepatitis due to hepatitis E virus genotype 1 as an imported infectious disease in Japan. Intern Med. 2010;49(23):2613–2616. PMID: 21139302. https://doi.org/10.2169/internalmedicine.49.4221

Kobayashi S, Mori A, Sugiyama R, Li TC, Fujii Y, Yato K, et al. Isolation and genome sequencing of hepatitis E virus genotype 1 imported from India to Japan. Jpn J Infect Dis. 2022;75(6):604–607. PMID: 35768276. https://doi.org/10.7883/yoken.JJID.2022.127

Matsumoto Y, Shimizu A, Ogawa K, Kuroki S, Ikuta K, Senda E, et al. Imported hepatitis E virus genotype 1: a rare case of acute hepatitis managed with steroid pulse therapy. Intern Med. 2024;63(3):393–397. PMID: 37286506. https://doi.org/10.2169/internalmedicine.1976‐23

Miyoshi M, Kakinuma S, Tanabe Y, Ishii K, Li TC, Wakita T, et al. Chronic hepatitis E infection in a persistently immunosuppressed patient unable to Be eliminated after ribavirin therapy. Intern Med. 2016;55(19):2811–2817. PMID: 27725541. https://doi.org/10.2169/internalmedicine.55.7025

Yoshida T, Takamura M, Goto R, Takeuchi S, Tsuchiya A, Kamimura K, et al. Efficacy and safety of ribavirin therapy for chronic hepatitis E after kidney transplantation. Hepatol Res. 2019;49(10):1244–1248. PMID: 31077507. https://doi.org/10.1111/hepr.13363

Okano H, Nakano T, Ito R, Tanaka A, Hoshi Y, Matsubayashi K, et al. The spontaneous clearance of hepatitis E virus (HEV) and emergence of HEV antibodies in a transfusion‐transmitted chronic hepatitis E case after completion of chemotherapy for acute myeloid leukemia. Clin J Gastroenterol. 2020;13(2):252–259. PMID: 31342463. https://doi.org/10.1007/s12328‐019‐01024‐3

Nitta S, Takahashi K, Kawai‐Kitahata F, Tsuchiya J, Sato A, Miyoshi M, et al. Time course alterations of virus sequences and immunoglobulin titers in a chronic hepatitis E patient. Hepatol Res. 2020;50(4):524–531. PMID: 31883166. https://doi.org/10.1111/hepr.13480

Takakusagi S, Takagi H, Yamazaki Y, Kosone T, Nagashima S, Takahashi M, et al. Chronic hepatitis E in an elderly immunocompetent patient who achieved a sustained virologic response with ribavirin treatment. Clin J Gastroenterol. 2023;16(2):206–215. PMID: 36403172. https://doi.org/10.1007/s12328‐022‐01733‐2

Yan J, Kanda T, Wu S, Imazeki F, Yokosuka O. Hepatitis A, B, C and E virus markers in Chinese residing in Tokyo, Japan. Hepatol Res. 2012;42(10):974–981. PMID: 22524475. https://doi.org/10.1111/j.1872‐034X.2012.01009.x

Inoue J, Takahashi M, Yazaki Y, Tsuda F, Okamoto H. Development and validation of an improved RT‐PCR assay with nested universal primers for detection of hepatitis E virus strains with significant sequence divergence. J Virol Methods. 2006;137(2):325–333. PMID: 16901555. https://doi.org/10.1016/j.jviromet.2006.07.004

Takahashi H, Tanaka T, Jirintai S, Nagashima S, Takahashi M, Nishizawa T, et al. A549 and PLC/PRF/5 cells can support the efficient propagation of swine and wild boar hepatitis E virus (HEV) strains: demonstration of HEV infectivity of porcine liver sold as food. Arch Virol. 2012;157(2):235–246. PMID: 22048607. https://doi.org/10.1007/s00705‐011‐1153‐2

Nishizawa T, Primadharsini PP, Namikawa M, Yamazaki Y, Uraki S, Okano H, et al. Full‐length genomic sequences of new subtype 1g hepatitis E virus strains obtained from four patients with imported or autochthonous acute hepatitis E in Japan. Infect Genet Evol. 2017;55:343–349. PMID: 28987806. https://doi.org/10.1016/j.meegid.2017.10.007

Inoue J, Ueno Y, Nagasaki F, Akahane T, Fukushima K, Kogure T, et al. Sporadic acute hepatitis E occurred constantly during the last decade in northeast Japan. J Gastroenterol. 2009;44(4):329–337. PMID: 19271116. https://doi.org/10.1007/s00535‐009‐0012‐3

Takikawa Y, Miyamoto Y, Onodera M, Kuroda H, Kasai K, Miyasaka A, et al. Icteric acute hepatitis E with no response of immunoglobulin M class anti‐hepatitis E virus antibody. Hepatol Res. 2012;42(11):1146–1149. PMID: 23094855. https://doi.org/10.1111/j.1872‐034X.2012.01023.x

Yazaki Y, Sugawara K, Honda M, Ohnishi H, Nagashima S, Takahashi M, et al. Characteristics of 20 patients with autochthonous acute hepatitis E in Hokkaido, Japan: first report of bilateral facial palsy following the infection with genotype 4 hepatitis E virus. Tohoku J Exp Med. 2015;236(4):263–271. PMID: 26228039. https://doi.org/10.1620/tjem.236.263

Inagaki Y, Oshiro Y, Imanishi M, Ishige K, Takahashi M, Okamoto H, et al. Acute infection by hepatitis E virus with a slight immunoglobulin M antibody response. Clin J Gastroenterol. 2015;8(4):247–252. PMID: 26215116. https://doi.org/10.1007/s12328‐015‐0589‐4

Mizuo H, Yazaki Y, Sugawara K, Tsuda F, Takahashi M, Nishizawa T, et al. Possible risk factors for the transmission of hepatitis E virus and for the severe form of hepatitis E acquired locally in Hokkaido, Japan. J Med Virol. 2005;76(3):341–349. PMID: 15902701. https://doi.org/10.1002/jmv.20364

Ohnishi S, Kang JH, Maekubo H, Arakawa T, Karino Y, Toyota J, et al. Comparison of clinical features of acute hepatitis caused by hepatitis E virus (HEV) genotypes 3 and 4 in Sapporo, Japan. Hepatol Res. 2006;36(4):301–307. PMID: 16971172. https://doi.org/10.1016/j.hepres.2006.08.002

Aikawa T, Miyamoto K, Ueno C, Kojima M, Takahashi M, Tsuda F, et al. A case of imported hepatitis E: identification of location of HEV infection by the molecular epidemiological approach. Kanzo. 2007;48(1):15–21. (in Japanese with English abstract). https://doi.org/10.2957/kanzo.48.15

Satta Y, Okuse C, Watanabe T, Suetani K, Ishigooka S, Matsunaga K, et al. Two cases of acute hepatitis with false positive for IgA HEV antibody. Kanzo. 2021;62(2):64–71. https://doi.org/10.2957/kanzo.62.64

Takahashi Y, Shimizu M. Aetiology and prognosis of fulminant viral hepatitis in Japan: a multicentre study. The Study Group of Fulminant Hepatitis. J Gastroenterol Hepatol. 1991;6(2):159–164. https://doi.org/10.1111/j.1440‐1746.1991.tb01458.x

Takahashi Y, Okuda K. Fulminant and subfulminant hepatitis in Japan‐‐etiological considerations. Indian J Gastroenterol. 1993;12(Suppl 3s):19–21.

Sugawara K, Nakayama N, Mochida S. Acute liver failure in Japan: definition, classification, and prediction of the outcome. J Gastroenterol. 2012;47(8):849–861. https://doi.org/10.1007/s00535‐012‐0624‐x

Mochida S, Nakayama N, Terai S, Yoshiji H, Shimizu M, Ido A, et al. Diagnostic criteria for acute‐on‐chronic liver failure and related disease conditions in Japan. Hepatol Res. 2022;52(5):417–421. https://doi.org/10.1111/hepr.13763

Takahashi K, Kang JH, Ohnishi S, Hino K, Miyakawa H, Miyakawa Y, et al. Full‐length sequences of six hepatitis E virus isolates of genotypes III and IV from patients with sporadic acute or fulminant hepatitis in Japan. Intervirology. 2003;46(5):308–318. PMID: 14555851. https://doi.org/10.1159/000073210

Inoue J, Nishizawa T, Takahashi M, Aikawa T, Mizuo H, Suzuki K, et al. Analysis of the full‐length genome of genotype 4 hepatitis E virus isolates from patients with fulminant or acute self‐limited hepatitis E. J Med Virol. 2006;78(4):476–484. PMID: 16482537. https://doi.org/10.1002/jmv.20565

Tsuge M, Noguchi C, Hiraga N, Mori N, Hiramatsu A, Imamura M, et al. A case of fulminant hepatic failure caused by hepatitis E virus. Clin J Gastroenterol. 2008;1(2):69–74. PMID: 26193466. https://doi.org/10.1007/s12328‐008‐0007‐2

Inoue J, Takahashi M, Mizuo H, Suzuki K, Aikawa T, Shimosegawa T, et al. Nucleotide substitutions of hepatitis E virus genomes associated with fulminant hepatitis and disease severity. Tohoku J Exp Med. 2009;218(4):279–284. PMID: 19638731. https://doi.org/10.1620/tjem.218.279

Shimata K, Sugawara Y, Yamamoto H, Okamoto H, Uchida K, Kawabata S, et al. A case report of living donor liver transplantation for fulminant hepatitis related to hepatitis E virus infection. Prog Transplant. 2018;28(1):91–92. PMID: 29226766. https://doi.org/10.1177/1526924817746912

Koyama M, Yamazaki T, Joshita S, Ito A, Ono K, Watanabe T, et al. An autopsy case of primary biliary cholangitis with histological submassive hepatic necrosis caused by acute hepatitis E virus infection. Intern Med. 2021;60(12):1863–1870. PMID: 33518570. https://doi.org/10.2169/internalmedicine.6337‐20

Ranjan A, Thakur S, Mokta J, Bhawani R, Ranjan V. Clinical profile and outcome of pregnant patients with acute HEV hepatitis during water borne epidemic in Himachal Pradesh: a hospital based study. J Assoc Physicians India. 2017;65(12):44–48. PMID: 29327522.

Frias M, López‐López P, Rivero A, Rivero‐Juarez A. Role of hepatitis E virus infection in acute‐on‐chronic liver failure. BioMed Res Int. 2018;2018:9098535–9098536. PMID: 30050945. https://doi.org/10.1155/2018/9098535

Li Q, Chen C, Huang C, Xu W, Hu Q, Chen L. Noninvasive models for predicting poor prognosis of chronic HBV infection patients precipitating acute HEV infection. Sci Rep. 2020;10(1):2753. PMID: 32066795. https://doi.org/10.1038/s41598‐020‐59670‐4

Choi JW, Son HJ, Lee SS, Jeon H, Cho JK, Kim HJ, et al. Acute hepatitis E virus superinfection increases mortality in patients with cirrhosis. BMC Infect Dis. 2022;22(1):62. PMID: 35042464. https://doi.org/10.1186/s12879‐022‐07050‐w

Zhao H, Ye W, Yu X, Hu J, Zhang X, Yang M, et al. Hepatitis E virus superinfection impairs long‐term outcome in hospitalized patients with hepatitis B virus‐related decompensated liver cirrhosis. Ann Hepatol. 2023;28(2):100878. PMID: 36417965. https://doi.org/10.1016/j.aohep.2022.100878

Chen C, Zhu A, Ye S, Li W, Fei L, Huang Q, et al. A new dyslipidemia‐based scoring model to predict transplant‐free survival in patients with hepatitis E‐triggered acute‐on‐chronic liver failure. Lipids Health Dis. 2023;22(1):80. PMID: 37355667. https://doi.org/10.1186/s12944‐023‐01826‐y

Jilani N, Das BC, Husain SA, Baweja UK, Chattopadhya D, Gupta RK, et al. Hepatitis E virus infection and fulminant hepatic failure during pregnancy. J Gastroenterol Hepatol. 2007;22(5):676–682. PMID: 17444855. https://doi.org/10.1111/j.1440‐1746.2007.04913.x

Kmush BL, Nelson KE, Labrique AB. Risk factors for hepatitis E virus infection and disease. Expert Rev Anti Infect Ther. 2015;13(1):41–53. PMID: 25399510. https://doi.org/10.1586/14787210.2015.981158

Haffar S, Shalimar, Kaur RJ, Wang Z, Prokop LJ, Murad MH, et al. Acute liver failure caused by hepatitis E virus genotype 3 and 4: a systematic review and pooled analysis. Liver Int. 2018;38(11):1965–1973. PMID: 29675889. https://doi.org/10.1111/liv.13861

Debes JD, Pas SD, Groothuismink ZMA, van der Ende ME, de Man RA, Boonstra A. A mutation in the progesterone receptor predisposes to HEV infection in HIV‐positive patients. Liver Int. 2018;38(5):792–796. PMID: 29285885. https://doi.org/10.1111/liv.13678

Bose PD, Das BC, Kumar A, Gondal R, Kumar D, Kar P. High viral load and deregulation of the progesterone receptor signaling pathway: association with hepatitis E‐related poor pregnancy outcome. J Hepatol. 2011;54(6):1107–1113. PMID: 21145845. https://doi.org/10.1016/j.jhep.2010.08.037

Debes JD, Groothuismink ZMA, de Man RA, Boonstra A. Association between a progesterone receptor mutation and hepatitis E sero‐positivity in liver transplant recipients. J Med Virol. 2020;92(12):3871–3874. PMID: 32603532. https://doi.org/10.1002/jmv.26236

Zhang L, Yesupriya A, Chang MH, Teshale E, Teo CG. Apolipoprotein E and protection against hepatitis E viral infection in American non‐Hispanic blacks. Hepatology. 2015;62(5):1346–1352. PMID: 26096528. https://doi.org/10.1002/hep.27938

Salih HS, Abbas AA. Detection of hepatitis E virus and toll‐like receptor 4 (rs4986790 and rs4986791) genotypes among A sample of hemodialysis patients. Iraqi Journal of Medical Sciences. 2023;21(1):145–153.

Nakamura M, Kanda T, Nakamoto S, Miyamura T, Jiang X, Wu S, et al. No correlation between PNPLA3 rs738409 genotype and fatty liver and hepatic cirrhosis in Japanese patients with HCV. PLoS One. 2013;8(12):e81312. PMID: 24349054. https://doi.org/10.1371/journal.pone.0081312

Mishra N, Arankalle VA. Association of polymorphisms in the promoter regions of TNF‐α (‐308) with susceptibility to hepatitis E virus and TNF‐α (‐1031) and IFN‐γ (+874) genes with clinical outcome of hepatitis E infection in India. J Hepatol. 2011;55(6):1227–1234. PMID: 21703188. https://doi.org/10.1016/j.jhep.2011.03.023

Smatti MK, Al‐Sarraj YA, Albagha O, Yassine HM. Genome‐wide association study identifies several loci for HEV seropositivity. iScience. 2023;26(9):107586. PMID: 37664632. https://doi.org/10.1016/j.isci.2023.107586

Copado‐Villagrana ED, Pizuorno A, García‐Suárez A, Abarca JC, DuPont G, Jaramillo‐Bueno S, et al. IL‐18 discriminates highly frequent hepatitis E virus positive from negative blood donors in Mexico. Ann Hepatol. 2023;28(5):101117. PMID: 37268060. https://doi.org/10.1016/j.aohep.2023.101117

Kar P, Jilani N, Husain SA, Pasha ST, Anand R, Rai A, et al. Does hepatitis E viral load and genotypes influence the final outcome of acute liver failure during pregnancy? Am J Gastroenterol. 2008;103(10):2495–2501. PMID: 18785952. https://doi.org/10.1111/j.1572‐0241.2008.02032.x

Bose PD, Das BC, Hazam RK, Kumar A, Medhi S, Kar P. Evidence of extrahepatic replication of hepatitis E virus in human placenta. J Gen Virol. 2014;95(Pt 6):1266–1271. PMID: 24622580. https://doi.org/10.1099/vir.0.063602‐0

Jeblaoui A, Haim‐Boukobza S, Marchadier E, Mokhtari C, Roque‐Afonso AM. Genotype 4 hepatitis e virus in france: an autochthonous infection with a more severe presentation. Clin Infect Dis. 2013;57(4):e122–e126. PMID: 23667262. https://doi.org/10.1093/cid/cit291

Jing W, Liu J, Liu M. The global trends and regional differences in incidence of HEV infection from 1990 to 2017 and implications for HEV prevention. Liver Int. 2021;41(1):58–69. PMID: 33025620. https://doi.org/10.1111/liv.14686

Li TC, Ochiai S, Ishiko H, Wakita T, Miyamura T, Takeda N. A retrospective study on imported hepatitis E in Japan. Trav Med Infect Dis. 2012;10(2):80–85. PMID: 22405678. https://doi.org/10.1016/j.tmaid.2012.02.003

Tripathy AS, Sharma M, Thorat NC, Jadhav S, Koshatwar KA. An outbreak of hepatitis E in Yavatmal, India, 2019. J Med Virol. 2021;93(6):3761–3768. PMID: 33617043. https://doi.org/10.1002/jmv.26377

Baki AA, Haque W, Giti S, Khan AA, Rahman MM, Jubaida N, et al. Hepatitis E virus genotype 1f outbreak in Bangladesh, 2018. J Med Virol. 2021;93(8):5177–5181. PMID: 33331650. https://doi.org/10.1002/jmv.26739

Hoa TN, Munshi SU, Ngoc KN, Ngoc CL, Thanh TTT, Akther T, et al. A tightly clustered hepatitis E virus genotype 1a is associated with endemic and outbreak infections in Bangladesh. PLoS One. 2021;16(7):e0255054. PMID: 34293039. https://doi.org/10.1371/journal.pone.0255054

Qian Z, Li T, Zhang Y, Chen S, Zhang H, Mickael HK, et al. Prevalence of hepatitis E virus and its association with adverse pregnancy outcomes in pregnant women in China. J Clin Virol. 2023;158:105353. PMID: 36527809. https://doi.org/10.1016/j.jcv.2022.105353

Dong R, Chang D, Luo Z, Zhang M, Guan Q, Shen C, et al. The burden of HEV‐related acute liver failure in Bangladesh, China and India: a systematic review and meta‐analysis. BMC Publ Health. 2023;23(1):2369. PMID: 38031080. https://doi.org/10.1186/s12889‐023‐17302‐2

Andersson MI, Hughes J, Gordon FH, Ijaz S, Donati M. Of pigs and pregnancy. Lancet. 2008;372(9644):1192. PMID: 18926280. https://doi.org/10.1016/S0140‐6736(08)61486‐5

Gouilly J, Chen Q, Siewiera J, Cartron G, Levy C, Dubois M, et al. Genotype specific pathogenicity of hepatitis E virus at the human maternal‐fetal interface. Nat Commun. 2018;9(1):4748. PMID: 30420629. https://doi.org/10.1038/s41467‐018‐07200‐2

Mishra N, Walimbe AM, Arankalle VA. Hepatitis E virus from India exhibits significant amino acid mutations in fulminant hepatic failure patients. Virus Gene. 2013;46(1):47–53. PMID: 23054435. https://doi.org/10.1007/s11262‐012‐0833‐7

Devhare P, Sharma K, Mhaindarkar V, Arankalle V, Lole K. Analysis of helicase domain mutations in the hepatitis E virus derived from patients with fulminant hepatic failure: effects on enzymatic activities and virus replication. Virus Res. 2014;184:103–110. PMID: 24630891. https://doi.org/10.1016/j.virusres.2014.02.018

Wang B, Tian D, Sooryanarain H, Mahsoub HM, Heffron CL, Hassebroek AM, et al. Two mutations in the ORF1 of genotype 1 hepatitis E virus enhance virus replication and may associate with fulminant hepatic failure. Proc Natl Acad Sci USA. 2022;119(34):e2207503119. PMID: 35969750. https://doi.org/10.1073/pnas.2207503119

Ikram A, Hakim MS, Zhou JH, Wang W, Peppelenbosch MP, Pan Q. Genotype‐specific acquisition, evolution and adaptation of characteristic mutations in hepatitis E virus. Virulence. 2018;9(1):121–132. PMID: 28727933. https://doi.org/10.1080/21505594.2017.1358349

Bagdassarian E, Doceul V, Pellerin M, Demange A, Meyer L, Jouvenet N, et al. The amino‐terminal region of hepatitis E virus ORF1 containing a methyltransferase (Met) and a Papain‐like cysteine protease (PCP) domain counteracts type I interferon response. Viruses. 2018;10(12):726. PMID: 30567349. https://doi.org/10.3390/v10120726

Lin S, Yang Y, Nan Y, Ma Z, Yang L, Zhang YJ. The capsid protein of hepatitis E virus inhibits interferon induction via its N‐terminal arginine‐rich motif. Viruses. 2019;11(11):1050. PMID: 31717991. https://doi.org/10.3390/v11111050

Borkakoti J, Ahmed G, Kar P. Report of a novel C1483W mutation in the hepatitis E virus polymerase in patients with acute liver failure. Infect Genet Evol. 2016;44:51–54. PMID: 27320795. https://doi.org/10.1016/j.meegid.2016.06.030

Borkakoti J, Ahmed G, Rai A, Kar P. Report of novel H105R, D29N, V27A mutations in the methyltransferase region of the HEV genome in patients with acute liver failure. J Clin Virol. 2017;91:1–4. PMID: 28359977. https://doi.org/10.1016/j.jcv.2017.03.017

Shinohara N, Owada T, Tanaka A, Matsubayashi K, Nagai T, Satake M. Hepatitis A virus and hepatitis E virus prevalence relates to human immunodeficiency virus infection in Japanese male blood donors. Microbiol Immunol. 2020;64(5):392–395. PMID: 32052883. https://doi.org/10.1111/1348‐0421.12780

Kitaura S, Wakabayashi Y, Okazaki A, Okada Y, Okamoto K, Ikeda M, et al. The first case report of acute symptomatic HEV genotype 4 infection in an HIV‐positive patient in Japan. Intern Med. 2020;59(13):1655–1658. PMID: 32269193. https://doi.org/10.2169/internalmedicine.4505‐20

Abravanel F, Lhomme S, Fougère M, Saune K, Alvarez M, Péron JM, et al. HEV infection in French HIV‐infected patients. J Infect. 2017;74(3):310–313. PMID: 27998748. https://doi.org/10.1016/j.jinf.2016.12.004

Migueres M, Ducours M, Dimeglio C, Trimoulet P, Abravanel F, Delobel P, et al. No evidence of sexual transmission of HEV among individuals using HIV pre‐exposure prophylaxis. J Viral Hepat. 2020;27(12):1495–1501. PMID: 32741049. https://doi.org/10.1111/jvh.13367

Chaix ML, Leturque N, Gabassi A, Charreau I, Minier M, Pialoux G, et al. Prevalence and incidence of HEV among men using HIV pre‐exposure prophylaxis: a sub‐study of the ANRS IPERGAY trial. J Clin Virol. 2023;160:105380. PMID: 36638749. https://doi.org/10.1016/j.jcv.2023.105380

Dauby N, Suin V, Jacques M, Abady M, Van Den Wijngaert S, Delforge M, et al. Hepatitis E virus (HEV): seroprevalence and HEV RNA detection in subjects attending a sexually transmitted infection clinic in Brussels, Belgium. Epidemiol Infect. 2017;145(16):3370–3374. PMID: 29103401. https://doi.org/10.1017/S0950268817002412

Greco L, Uceda Renteria SC, Guarneri D, Orlandi A, Zoccoli A, Benardon S, et al. HEV and HAV seroprevalence in men that have sex with men (MSM): an update from Milan, Italy. J Med Virol. 2018;90(8):1323–1327. PMID: 29446470. https://doi.org/10.1002/jmv.25052

Spada E, Costantino A, Pezzotti P, Bruni R, Pisani G, Madonna E, et al. Hepatitis E virus infection prevalence among men who have sex with men involved in a hepatitis A virus outbreak in Italy. Blood Transfus. 2019;17(6):428–432. PMID: 31846607. https://doi.org/10.2450/2019.0209‐19

Alberts CJ, Schim van der Loeff MF, Sadik S, Zuure FR, Beune EJAJ, Prins M, et al. Hepatitis E virus seroprevalence and determinants in various study populations in The Netherlands. PLoS One. 2018;13(12):e0208522. PMID: 30557324. https://doi.org/10.1371/journal.pone.0208522

Lin KY, Lin PH, Sun HY, Chen YT, Su LH, Su YC, et al. Hepatitis E virus infections among human immunodeficiency virus‐positive individuals during an outbreak of acute hepatitis A in Taiwan. Hepatology. 2019;70(6):1892–1902. PMID: 31100186. https://doi.org/10.1002/hep.30771

Rodríguez‐Tajes S, Perpiñán E, Leonel T, Lens S, Mariño Z, Pérez‐Del‐Pulgar S, et al. Low seroprevalence and zero incidence rate of hepatitis E in men who have sex with men during a hepatitis A outbreak. J Med Virol. 2020;92(8):1359–1362. PMID: 31743439. https://doi.org/10.1002/jmv.25630

Péron JM, Bureau C, Poirson H, Mansuy JM, Alric L, Selves J, et al. Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy. J Viral Hepat. 2007;14(5):298–303. PMID: 17439518. https://doi.org/10.1111/j.1365‐2893.2007.00858.x

Pischke S, Wedemeyer H. Chronic hepatitis E in liver transplant recipients: a significant clinical problem? Minerva Gastroenterol Dietol. 2010;56(2):121–128. PMID: 20485250.

Sayed IM, El‐Mokhtar MA, Mahmoud MAR, Elkhawaga AA, Gaber S, Seddek NH, et al. Clinical outcomes and prevalence of hepatitis E virus (HEV) among non‐A‐C hepatitis patients in Egypt. Infect Drug Resist. 2021;14:59–69. PMID: 33469320. https://doi.org/10.2147/IDR.S289766

Gabrielli F, Alberti F, Russo C, Cursaro C, Seferi H, Margotti M, et al. Treatment options for hepatitis A and E: a non‐systematic review. Viruses. 2023;15(5):1080. PMID: 37243166. https://doi.org/10.3390/v15051080

Ramsay I, Snell L, Sharma V, O'Beirne J, Patch D, Marshall A, et al. Liver transplantation for acute liver failure because of genotype 3 hepatitis E virus infection. Liver Transplant. 2015;21(12):1557–1559. PMID: 26178234. https://doi.org/10.1002/lt.24213

Fang L, Zhang J, Chen H, Lv F, Yu Y, Du X. Epidemiological characteristics and clinical manifestations of hepatitis E in a tertiary hospital in China: a retrospective study. Front Microbiol. 2022;12:831968. PMID: 35310389. https://doi.org/10.3389/fmicb.2021.831968

Viera‐Segura O, Panduro A, Trujillo‐Ochoa JL, Copado‐Villagrana E, Torres‐Valadez R, Sepulveda‐Villegas M, et al. Evidence for increased inflammatory cytokine profile in hepatitis E virus‐infected obese patients: implications for chronic liver disease. Viral Immunol. 2020;33(9):600–609. PMID: 32986530. https://doi.org/10.1089/vim.2020.0064

Sridhar S, Lo SK, Xing F, Yang J, Ye H, Chan JF, et al. Clinical characteristics and molecular epidemiology of hepatitis E in Shenzhen, China: a shift toward foodborne transmission of hepatitis E virus infection. Emerg Microb Infect. 2017;6(12):e115–e116. PMID: 29259325. https://doi.org/10.1038/emi.2017.107

Murthy KA, Khan IM, Kiran PK, Hakeem H. A study of viral hepatitis e infection in a tertiary care hospital in Mysore, South India. Open Forum Infect Dis. 2014;1(1):ofu036. PMID: 25734105. https://doi.org/10.1093/ofid/ofu036

Wenter C, Borena W, Oberhuber G, Graziadei I. Acute liver failure in immunocompetent patients infected with hepatitis E. Wien Klin Wochenschr. 2019;131(17‐18):442–445. PMID: 31493102. https://doi.org/10.1007/s00508‐019‐01547‐2

Aherfi S, Borentain P, Raissouni F, Le Goffic A, Guisset M, Renou C, et al. Liver transplantation for acute liver failure related to autochthonous genotype 3 hepatitis E virus infection. Clin Res Hepatol Gastroenterol. 2014;38(1):24–31. PMID: 24462173. https://doi.org/10.1016/j.clinre.2013.05.013

Gynthersen RMM, Rønn CP, Brandt CT, Mens H. Severe acute hepatitis E infection presenting with acute abdomen and meningoencephalitis. BMJ Case Rep. 2020;13(12):e236922. PMID: 33318241. https://doi.org/10.1136/bcr‐2020‐236922

Fantilli A, López Villa SD, Zerega A, Di Cola G, López L, Wassaf MM, et al. Hepatitis E virus infection in a patient with alcohol related chronic liver disease: a case report of acute‐on‐chronic liver failure. Virol J. 2021;18(1):245. PMID: 34886883. https://doi.org/10.1186/s12985‐021‐01714‐w

Peroni E, Mora P, Motte A, Gerolami R, Aherfi S, Colson P. Fatal fulminant hepatitis E in a diabetic patient on metformin. Diagnostics. 2022;12(10):2385. PMID: 36292073. https://doi.org/10.3390/diagnostics12102385

Zhang A, Sun H, Wang X. Serum metabolomics as a novel diagnostic approach for disease: a systematic review. Anal Bioanal Chem. 2012;404(4):1239–1245. PMID: 22648167. https://doi.org/10.1007/s00216‐012‐6117‐1

Wu J, Xu Y, Cui Y, Bortolanza M, Wang M, Jiang B, et al. Dynamic changes of serum metabolites associated with infection and severity of patients with acute hepatitis E infection. J Med Virol. 2022;94(6):2714–2726. PMID: 35199373. https://doi.org/10.1002/jmv.27669

Khongviwatsathien S, Thaweerat W, Atthakitmongkol T, Chotiyaputta W, Tanwandee T. A comparison of clinical manifestations and outcomes between acute sporadic hepatitis A and hepatitis E infections in Thailand. Viruses. 2023;15(9):1888. PMID: 37766294. https://doi.org/10.3390/v15091888

Baymakova M, Kunchev M, Mihaylova‐Garnizova R, Zasheva A, Plochev K, Kundurzhiev T, et al. Comparative analysis on clinical characteristics among patients with acute hepatitis A virus (HAV) and patients with acute hepatitis E virus (HEV): a single‐center retrospective study from Bulgaria. Infect Drug Resist. 2023;16:3349–3366. PMID: 37274360. https://doi.org/10.2147/IDR.S411606

El‐Mokhtar MA, Elkhawaga AA, Ahmed MSH, El‐Sabaa EMW, Mosa AA, Abdelmohsen AS, et al. High incidence of acute liver failure among patients in Egypt coinfected with hepatitis A and hepatitis E viruses. Microorganisms. 2023;11(12):2898. https://doi.org/10.3390/microorganisms11122898

Dalton HR, Kamar N, Baylis SA, Moradpour D, Wedemeyer H, Negro F. EASL Clinical practice guidelines on hepatitis E virus infection. J Hepatol. 2018;68(6):1256–1271. PMID: 29609832. https://doi.org/10.1016/j.jhep.2018.03.005

Kamar N, Rostaing L, Legrand‐Abravanel F, Izopet J. How should hepatitis E virus infection be defined in organ‐transplant recipients? Am J Transplant. 2013;13(7):1935–1936. PMID: 23659713. https://doi.org/10.1111/ajt.12253

Oshiro Y, Harada H, Hasegawa K, Akutsu N, Yoshizumi T, Kawagishi N, et al. Loss of antibodies to hepatitis E virus in organ transplant patients with hepatitis E. Hepatol Res. 2021;51(5):538–547. PMID: 33749100. https://doi.org/10.1111/hepr.13637

Tamura A, Shimizu YK, Tanaka T, Kuroda K, Arakawa Y, Takahashi K, et al. Persistent infection of hepatitis E virus transmitted by blood transfusion in a patient with T‐cell lymphoma. Hepatol Res. 2007;37(2):113–120. PMID: 17300706. https://doi.org/10.1111/j.1872‐034X.2007.00024.x

Takahashi M, Hoshino Y, Tanaka T, Takahashi H, Nishizawa T, Okamoto H. Production of monoclonal antibodies against hepatitis E virus capsid protein and evaluation of their neutralizing activity in a cell culture system. Arch Virol. 2008;153(4):657–666. PMID: 18266052. https://doi.org/10.1007/s00705‐008‐0045‐6

Inagaki Y, Oshiro Y, Hasegawa N, Fukuda K, Abei M, Nishi M, et al. Clinical features of hepatitis E virus infection in Ibaraki, Japan: autochthonous hepatitis E and acute‐on‐chronic liver failure. Tohoku J Exp Med. 2015;235(4):275–282. PMID: 25797216. https://doi.org/10.1620/tjem.235.275

Fuse K, Matsuyama Y, Moriyama M, Miyakoshi S, Shibasaki Y, Takizawa J, et al. Late onset post‐transfusion hepatitis E developing during chemotherapy for acute promyelocytic leukemia. Intern Med. 2015;54(6):657–661. PMID: 25786459. https://doi.org/10.2169/internalmedicine.54.2332

Fujiwara S, Yokokawa Y, Morino K, Hayasaka K, Kawabata M, Shimizu T. Chronic hepatitis E: a review of the literature. J Viral Hepat. 2014;21(2):78–89. PMID: 24383921. https://doi.org/10.1111/jvh.12156

Grewal P, Kamili S, Motamed D. Chronic hepatitis E in an immunocompetent patient: a case report. Hepatology. 2014;59(1):347–348. PMID: 23913727. https://doi.org/10.1002/hep.26636

Höner zu Siederdissen C, Pischke S, Schlue J, Deterding K, Hellms T, Schuler‐Lüttmann S, et al. Chronic hepatitis E virus infection beyond transplantation or human immunodeficiency virus infection. Hepatology. 2014;60(3):1112–1113. PMID: 24375747. https://doi.org/10.1002/hep.26987

Barragué H, Condat B, Petitdidier N, Champagne E, Renou C, Izopet J, et al. Chronic hepatitis E virus infection in a cirrhotic patient: a case report. Medicine (Baltim). 2017;96(39):e7915. PMID: 28953614. https://doi.org/10.1097/MD.0000000000007915

Kamar N, Mansuy JM, Cointault O, Selves J, Abravanel F, Danjoux M, et al. Hepatitis E virus‐related cirrhosis in kidney‐ and kidney‐pancreas‐transplant recipients. Am J Transplant. 2008;8(8):1744–1748. PMID: 18557740. https://doi.org/10.1111/j.1600‐6143.2008.02286.x

Schlosser B, Stein A, Neuhaus R, Pahl S, Ramez B, Krüger DH, et al. Liver transplant from a donor with occult HEV infection induced chronic hepatitis and cirrhosis in the recipient. J Hepatol. 2012;56(2):500–502. PMID: 21798217. https://doi.org/10.1016/j.jhep.2011.06.021

Lhomme S, Abravanel F, Dubois M, Sandres‐Saune K, Rostaing L, Kamar N, et al. Hepatitis E virus quasispecies and the outcome of acute hepatitis E in solid‐organ transplant patients. J Virol. 2012;86(18):10006–10014. PMID: 22761386. https://doi.org/10.1128/JVI.01003‐12

Riveiro‐Barciela M, Buti M, Homs M, Campos‐Varela I, Cantarell C, Crespo M, et al. Cirrhosis, liver transplantation and HIV infection are risk factors associated with hepatitis E virus infection. PLoS One. 2014;9(7):e103028. PMID: 25068388. https://doi.org/10.1371/journal.pone.0103028

Xu B, Yu HB, Hui W, He JL, Wei LL, Wang Z, et al. Clinical features and risk factors of acute hepatitis E with severe jaundice. World J Gastroenterol. 2012;18(48):7279–7284. PMID: 23326133. https://doi.org/10.3748/wjg.v18.i48.7279

Mechnik L, Bergman N, Attali M, Beergabel M, Mosenkis B, Sokolowski N, et al. Acute hepatitis E virus infection presenting as a prolonged cholestatic jaundice. J Clin Gastroenterol. 2001;33(5):421–422. PMID: 11606863. https://doi.org/10.1097/00004836‐200111000‐00017

Moucari R, Bernuau J, Nicand E, Cazals‐hatem D, Valla D, Marcellin P, et al. Acute hepatitis E with severe jaundice: report of three cases. Eur J Gastroenterol Hepatol. 2007;19(11):1012–1015. PMID: 18049173. https://doi.org/10.1097/MEG.0b013e328209414d

Agrawal V, Goel A, Rawat A, Naik S, Aggarwal R. Histological and immunohistochemical features in fatal acute fulminant hepatitis E. Indian J Pathol Microbiol. 2012;55(1):22–27. PMID: 22499295. https://doi.org/10.4103/0377‐4929.94849

Jain J, Jain M. Atypical manifestations of viral hepatitis A and E. Trop Doct. 2013;43(1):17–18. PMID: 23492922. https://doi.org/10.1177/0049475513480497

Pokhrel S, Bhusal A, Kumari N, Bhattarai HB, Banjade A. Hepatitis‐E‐induced cholestasis in a child: a case report. Ann Med Surg (Lond). 2023;85(6):3039–3042. PMID: 37363502. https://doi.org/10.1097/MS9.0000000000000748

Kamar N, Weclawiak H, Guilbeau‐Frugier C, Legrand‐Abravanel F, Cointault O, Ribes D, et al. Hepatitis E virus and the kidney in solid‐organ transplant patients. Transplantation. 2012;93(6):617–623. PMID: 22298032. https://doi.org/10.1097/TP.0b013e318245f14c

Taton B, Moreau K, Lepreux S, Bachelet T, Trimoulet P, De LV, et al. Hepatitis E virus infection as a new probable cause of de novo membranous nephropathy after kidney transplantation. Transpl Infect Dis. 2013;15(6):E211–E215. PMID: 24103101. https://doi.org/10.1111/tid.12143

Guinault D, Ribes D, Delas A, Milongo D, Abravanel F, Puissant‐Lubrano B, et al. Hepatitis E virus‐induced cryoglobulinemic glomerulonephritis in a nonimmunocompromised person. Am J Kidney Dis. 2016;67(4):660–663. PMID: 26682764. https://doi.org/10.1053/j.ajkd.2015.10.022

Del Bello A, Guilbeau‐Frugier C, Josse AG, Rostaing L, Izopet J, Kamar N. Successful treatment of hepatitis E virus‐associated cryoglobulinemic membranoproliferative glomerulonephritis with ribavirin. Transpl Infect Dis. 2015;17(2):279–283. PMID: 25708383. https://doi.org/10.1111/tid.12353

Elkhawaga AA, El‐Mokhtar MA, Mahmoud AA, Ali WE, Mohamed DS, Kamel AM, et al. First report on abnormal renal function in acute hepatitis E genotype 1 infection. Pathogens. 2023;12(5):687. PMID: 37242358. https://doi.org/10.3390/pathogens12050687

El‐Mokhtar MA, Kamel AM, El‐Sabaa EMW, Mandour SA, Abdelmohsen AS, Moussa AM, et al. Evidence of a link between hepatitis E virus exposure and glomerulonephritis development. Viruses. 2023;15(6):1379. PMID: 37376678. https://doi.org/10.3390/v15061379

Bazerbachi F, Leise MD, Watt KD, Murad MH, Prokop LJ, Haffar S. Systematic review of mixed cryoglobulinemia associated with hepatitis E virus infection: association or causation? Gastroenterol Rep (Oxf). 2017;5(3):178–184. PMID: 28852522. https://doi.org/10.1093/gastro/gox021

Ramos‐Casals M, Stone JH, Cid MC, Bosch X. The cryoglobulinaemias. Lancet. 2012;379(9813):348–360. PMID: 21868085. https://doi.org/10.1016/S0140‐6736(11)60242‐0

Pischke S, Behrendt P, Manns MP, Wedemeyer H. HEV‐associated cryoglobulinaemia and extrahepatic manifestations of hepatitis E. Lancet Infect Dis. 2014;14(8):678–679. PMID: 25056019. https://doi.org/10.1016/S1473‐3099(14)70823‐0

Kitazawa T, Ota Y, Suzuki M, Morisawa Y, Shintani Y, Koike K, et al. Acute hepatitis E with elevated creatine phosphokinase. Intern Med. 2003;42(9):899–902. PMID: 14518686. https://doi.org/10.2169/internalmedicine.42.899

van Eijk JJ, Madden RG, van der Eijk AA, Hunter JG, Reimerink JH, Bendall RP, et al. Neuralgic amyotrophy and hepatitis E virus infection. Neurology. 2014;82(6):498–503. PMID: 24401685. https://doi.org/10.1212/WNL.0000000000000112

van den Berg B, van der Eijk AA, Pas SD, Hunter JG, Madden RG, Tio‐Gillen AP, et al. Guillain‐Barré syndrome associated with preceding hepatitis E virus infection. Neurology. 2014;82(6):491–497. PMID: 24415572. https://doi.org/10.1212/WNL.0000000000000111

Shah SA, Lal A, Idrees M, Hussain A, Jeet C, Malik FA, et al. Hepatitis E virus‐associated aplastic anaemia: the first case of its kind. J Clin Virol. 2012;54(1):96–97. PMID: 22441030. https://doi.org/10.1016/j.jcv.2012.02.002

Chen Z, Wei J, Jiang L, Ying D, Tian W, Zhang M, et al. Case Report: chronic hepatitis E in a hematopoietic stem cell transplant recipient: the first report of hepatitis E virus genotype 4 causing chronic infection in a non‐solid organ recipient. Front Immunol. 2022;13:954697. PMID: 36275730. https://doi.org/10.3389/fimmu.2022.954697

al‐Fawaz I, al‐Rasheed S, al‐Mugeiren M, al‐Salloum A, al‐Sohaibani M, Ramia S. Hepatitis E virus infection in patients from Saudi Arabia with sickle cell anaemia and beta‐thalassemia major: possible transmission by blood transfusion. J Viral Hepat. 1996;3(4):203–205. PMID: 8871882. https://doi.org/10.1111/j.1365‐2893.1996.tb00096.x

Irshad M, Peter S. Spectrum of viral hepatitis in thalassemic children receiving multiple blood transfusions. Indian J Gastroenterol. 2002;21(5):183–184. PMID: 12416747.

Abdelmawla D, Moemen D, Darwish A, Mowafy W. Hepatitis E virus prevalence in Egyptian children with transfusion‐dependent thalassemia. Braz J Infect Dis. 2019;23(1):40–44. PMID: 30826379. https://doi.org/10.1016/j.bjid.2019.01.007

Slavov SN, Maçonetto JDM, Martinez EZ, Silva‐Pinto AC, Covas DT, Eis‐Hübinger AM, et al. Prevalence of hepatitis E virus infection in multiple transfused Brazilian patients with thalassemia and sickle cell disease. J Med Virol. 2019;91(9):1693–1697. PMID: 31066064. https://doi.org/10.1002/jmv.25498

Farshadpour F, Taherkhani R, Shaeri M. Prevalence and risk factors of hepatitis E virus infection among patients with β‐thalassemia major in South of Iran. J Immunoassay Immunochem. 2022;43(4):452–462. PMID: 35230202. https://doi.org/10.1080/15321819.2022.2046602

Thapa R, Biswas B, Mallick D, Ghosh A. Acute pancreatitis‐‐complicating hepatitis E virus infection in a 7‐year‐old boy with glucose 6 phosphate dehydrogenase deficiency. Clin Pediatr (Phila). 2009;48(2):199–201. PMID: 19129425. https://doi.org/10.1177/0009922808327107

Tomar LR, Aggarwal A, Jain P, Rajpal S, Agarwal MP. Acute viral hepatitis E presenting with haemolytic anaemia and acute renal failure in a patient with glucose‐6‐phosphate dehydrogenase deficiency. Trop Doct. 2015;45(4):245–246. PMID: 25500531. https://doi.org/10.1177/0049475514559959

Riveiro‐Barciela M, Bes M, Quer J, Valcarcel D, Piriz S, Gregori J, et al. Thrombotic thrombocytopenic purpura relapse induced by acute hepatitis E transmitted by cryosupernatant plasma and successfully controlled with ribavirin. Transfusion. 2018;58(11):2501–2505. PMID: 30284732. https://doi.org/10.1111/trf.14831

Lv F, Zhao Y, Yang XD, Chen HZ, Ren WY, Chen LX, et al. Acute hepatitis E induced the first episode of immune‐mediated thrombotic thrombocytopenic purpura: the first case report. Infect Drug Resist. 2023;16:5149–5154. PMID: 37581168. https://doi.org/10.2147/IDR.S418430

Kamar N, Bendall RP, Peron JM, Cintas P, Prudhomme L, Mansuy JM, et al. Hepatitis E virus and neurologic disorders. Emerg Infect Dis. 2011;17(2):173–179. PMID: 21291585. https://doi.org/10.3201/eid1702.100856

Maurissen I, Jeurissen A, Strauven T, Sprengers D, De Schepper B. First case of anti‐ganglioside GM1‐positive Guillain‐Barré syndrome due to hepatitis E virus infection. Infection. 2012;40(3):323–326. PMID: 21877179. https://doi.org/10.1007/s15010‐011‐0185‐6

Scharn N, Ganzenmueller T, Wenzel JJ, Dengler R, Heim A, Wegner F. Guillain‐Barré syndrome associated with autochthonous infection by hepatitis E virus subgenotype 3c. Infection. 2014;42(1):171–173. PMID: 23512540. https://doi.org/10.1007/s15010‐013‐0448‐5

Higuchi MA, Fukae J, Tsugawa J, Ouma S, Takahashi K, Mishiro S, et al. Dysgeusia in a patient with guillain‐barré syndrome associated with acute hepatitis E: a case report and literature review. Intern Med. 2015;54(12):1543–1546. PMID: 26073247. https://doi.org/10.2169/internalmedicine.54.3506

Fukae J, Tsugawa J, Ouma S, Umezu T, Kusunoki S, Tsuboi Y. Guillain‐Barré and Miller Fisher syndromes in patients with anti‐hepatitis E virus antibody: a hospital‐based survey in Japan. Neurol Sci. 2016;37(11):1849–1851. PMID: 27389141. https://doi.org/10.1007/s10072‐016‐2644‐4

Stevens O, Claeys KG, Poesen K, Saegeman V, Van Damme P. Diagnostic challenges and clinical characteristics of hepatitis E virus‐associated guillain‐barré syndrome. JAMA Neurol. 2017;74(1):26–33. PMID: 27820624. https://doi.org/10.1001/jamaneurol.2016.3541

Tian D, Li W, Heffron CL, Wang B, Mahsoub HM, Sooryanarain H, et al. Hepatitis E virus infects brain microvascular endothelial cells, crosses the blood‐brain barrier, and invades the central nervous system. Proc Natl Acad Sci USA. 2022;119(24):e2201862119. PMID: 35671427. https://doi.org/10.1073/pnas.2201862119

Rianthavorn P, Thongmee C, Limpaphayom N, Komolmit P, Theamboonlers A, Poovorawan Y. The entire genome sequence of hepatitis E virus genotype 3 isolated from a patient with neuralgic amyotrophy. Scand J Infect Dis. 2010;42(5):395–400. PMID: 20100114. https://doi.org/10.3109/00365540903496551

Theochari E, Vincent‐Smith L, Ellis C. Neuralgic amyotrophy complicating acute hepatitis E infection: a rare association. BMJ Case Rep. 2015;2015:bcr2014207669. PMID: 25739795. https://doi.org/10.1136/bcr‐2014‐207669

Dartevel A, Colombe B, Bosseray A, Larrat S, Sarrot‐Reynauld F, Belbezier A, et al. Hepatitis E and neuralgic amyotrophy: five cases and review of literature. J Clin Virol. 2015;69:156–164. PMID: 26209399. https://doi.org/10.1016/j.jcv.2015.06.091

Scanvion Q, Perez T, Cassim F, Outteryck O, Lanteri A, Hatron PY, et al. Neuralgic amyotrophy triggered by hepatitis E virus: a particular phenotype. J Neurol. 2017;264(4):770–780. PMID: 28247042. https://doi.org/10.1007/s00415‐017‐8433‐z

van Eijk JJJ, Dalton HR, Ripellino P, Madden RG, Jones C, Fritz M, et al. Clinical phenotype and outcome of hepatitis E virus‐associated neuralgic amyotrophy. Neurology. 2017;89(9):909–917. PMID: 28768846. https://doi.org/10.1212/WNL.0000000000004297

Wiesenfarth M, Stamminger T, Zizer E, Tumani H, Ludolph AC. Neurological manifestation of HEV infection: still a rare disease entity? J Neurol. 2024;271(1):386–394. PMID: 37737892. https://doi.org/10.1007/s00415‐023‐11985‐8

Makharia GK, Garg PK, Tandon RK. Acute pancreatitis associated with acute hepatitis E infection. Trop Gastroenterol. 2003;24(4):200–201. PMID: 15164533.

Jaroszewicz J, Flisiak R, Kalinowska A, Wierzbicka I, Prokopowicz D. Acute hepatitis E complicated by acute pancreatitis: a case report and literature review. Pancreas. 2005;30(4):382–384. PMID: 15841052. https://doi.org/10.1097/01.mpa.0000160962.06333.17

Somani SK, Ghosh A, Awasthi G. Severe acute pancreatitis with pseudocyst bleeding due to hepatitis E virus infection. Clin J Gastroenterol. 2009;2(1):39–42. PMID: 26191807. https://doi.org/10.1007/s12328‐008‐0035‐y

Karlsson M, Norder H, Bergström M, Park PO, Karlsson M, Wejstål R, et al. Hepatitis E virus genotype 3 is associated with gallstone‐related disease. Scand J Gastroenterol. 2019;54(10):1269–1273. PMID: 31553628. https://doi.org/10.1080/00365521.2019.1666163

Beer A, Holzmann H, Pischke S, Behrendt P, Wrba F, Schlue J, et al. Chronic Hepatitis E is associated with cholangitis. Liver Int. 2019;39(10):1876–1883. PMID: 31102493. https://doi.org/10.1111/liv.14137

Hirano R, Kanda T, Honda M, Arima S, Totsuka M, Masuzaki R, et al. Hepatitis E virus infection caused elevation of alanine aminotransferase levels in a patient with chronic hepatitis B and choledocholithiasis. Reports. 2023;6(4):55. https://doi.org/10.3390/reports6040055

Wu J, Xiang Z, Gao C, Huang L, Hua J, Tong L, et al. Genotype 4 HEV infection triggers the initiation and development of acute pancreatitis. Microb Infect. 2023;25(8):105190. PMID: 37499789. https://doi.org/10.1016/j.micinf.2023.105190

Dalton B, Cunnane G, Conway R. Acute hepatitis E in an immunocompromised patient with seropositive rheumatoid arthritis on rituximab and long‐term methotrexate. Mod Rheumatol Case Rep. 2021;5(2):226–228. PMID: 33783311. https://doi.org/10.1080/24725625.2021.1905204

Bauer H, Luxembourger C, Gottenberg JE, Fournier S, Abravanel F, Cantagrel A, et al. Outcome of hepatitis E virus infection in patients with inflammatory arthritides treated with immunosuppressants: a French retrospective multicenter study. Medicine (Baltim). 2015;94(14):e675. PMID: 25860212. https://doi.org/10.1097/MD.0000000000000675

Kanda T, Yasui S, Nakamura M, Arai M, Sasaki R, Haga Y, et al. Recent trend of hepatitis E virus infection in chiba area, Japan: 3 of 5 cases with rheumatoid arthritis. Case Rep Gastroenterol. 2015;9(3):317–326. PMID: 26600768. https://doi.org/10.1159/000441387

Thodou V, Buechter M, Manka P, Gerken G, Kahraman A. Course of hepatitis E infection in a patient with rheumatoid arthritis and autoimmune hepatitis: a case report. Medicine (Baltim). 2017;96(51):e9407. PMID: 29390558. https://doi.org/10.1097/MD.0000000000009407

Ikeuchi H, Koinuma K, Nakasatomi M, Sakairi T, Kaneko Y, Maeshima A, et al. Hepatitis E during tocilizumab therapy in a patient with rheumatoid arthritis: case report and literature review. Case Rep Rheumatol. 2018;2018:6873276. PMID: 30147981. https://doi.org/10.1155/2018/6873276

Pischke S, Peron JM, von Wulffen M, von Felden J, Höner Zu Siederdissen C, Fournier S, et al. Chronic hepatitis E in rheumatology and internal medicine patients: a retrospective multicenter European cohort study. Viruses. 2019;11(2):186. PMID: 30813268. https://doi.org/10.3390/v11020186

Kinast V, Andreica I, Ahrenstorf G, Gömer A, Elsner C, Schlienkamp S, et al. Janus kinase‐inhibition modulates hepatitis E virus infection. Antivir Res. 2023;217:105690. PMID: 37517633. https://doi.org/10.1016/j.antiviral.2023.105690

Premkumar M, Rangegowda D, Vashishtha C, Bhatia V, Khumuckham JS, Kumar B. Acute viral hepatitis e is associated with the development of myocarditis. Case Reports Hepatol. 2015;2015:458056. PMID: 25802773. https://doi.org/10.1155/2015/458056

Dumoulin FL, Liese H. Acute hepatitis E virus infection and autoimmune thyroiditis: yet another trigger? BMJ Case Rep. 2012;2012(apr23 1):bcr1220115441. PMID: 22604767. https://doi.org/10.1136/bcr.12.2011.5441

Belbezier A, Deroux A, Sarrot‐Reynauld F, Larrat S, Bouillet L. Myasthenia gravis associated with acute hepatitis E infection in immunocompetent woman. Emerg Infect Dis. 2014;20(5):908–910. PMID: 24751295. https://doi.org/10.3201/eid2005.131551

Johne R, Trojnar E, Filter M, Hofmann J. Thermal stability of hepatitis E virus as estimated by a cell culture method. Appl Environ Microbiol. 2016;82(14):4225–4231. PMID: 27208095. https://doi.org/10.1128/AEM.00951‐16

Imagawa T, Sugiyama R, Shiota T, Li TC, Yoshizaki S, Wakita T, et al. Evaluation of heating conditions for inactivation of hepatitis E virus genotypes 3 and 4. J Food Protect. 2018;81(6):947–952. PMID: 29745758. https://doi.org/10.4315/0362‐028X.JFP‐17‐290

Barnaud E, Rogée S, Garry P, Rose N, Pavio N. Thermal inactivation of infectious hepatitis E virus in experimentally contaminated food. Appl Environ Microbiol. 2012;78(15):5153–5159. PMID: 22610436. https://doi.org/10.1128/AEM.00436‐12

Tanaka T, Takahashi M, Kusano E, Okamoto H. Development and evaluation of an efficient cell‐culture system for Hepatitis E virus. J Gen Virol. 2007;88(Pt 3):903–911. PMID: 17325363. https://doi.org/10.1099/vir.0.82535‐0

Behrendt P, Friesland M, Wißmann JE, Kinast V, Stahl Y, Praditya D, et al. Hepatitis E virus is highly resistant to alcohol‐based disinfectants. J Hepatol. 2022;76(5):1062–1069. PMID: 35085595. https://doi.org/10.1016/j.jhep.2022.01.006

Wißmann JE, Brüggemann Y, Todt D, Steinmann J, Steinmann E. Survival and inactivation of hepatitis E virus on inanimate surfaces. J Hosp Infect. 2023;134:57–62. PMID: 36746308. https://doi.org/10.1016/j.jhin.2023.01.013

Praditya D, Friesland M, Gravemann U, Handke W, Todt D, Behrendt P, et al. Hepatitis E virus is effectively inactivated in platelet concentrates by ultraviolet C light. Vox Sang. 2020;115(7):555–561. PMID: 32383163. https://doi.org/10.1111/vox.12936

Joshi YK, Babu S, Sarin S, Tandon BN, Gandhi BM, Chaturvedi VC. Immunoprophylaxis of epidemic non‐A non‐B hepatitis. Indian J Med Res. 1985;81:18–19. PMID: 3921458.

Khuroo MS, Dar MY. Hepatitis E: evidence for person‐to‐person transmission and inability of low dose immune serum globulin from an Indian source to prevent it. Indian J Gastroenterol. 1992;11(3):113–116. PMID: 1506045.

Aggarwal R, Krawczynski K. Hepatitis E: an overview and recent advances in clinical and laboratory research. J Gastroenterol Hepatol. 2000;15(1):9–20. PMID: 10719741. https://doi.org/10.1046/j.1440‐1746.2000.02006.x

Kobayashi T, Takahashi M, Ohta S, Nagashima S, Primadharsini PP, Kunita S, et al. Production of capsid proteins of rat hepatitis E virus in Escherichia coli and characterization of self‐assembled virus‐like particles. Virus Res. 2021;302:198483. PMID: 34146611. https://doi.org/10.1016/j.virusres.2021.198483

Li Y, Huang X, Zhang Z, Li S, Zhang J, Xia N, et al. Prophylactic hepatitis E vaccines: antigenic analysis and serological evaluation. Viruses. 2020;12(1):109. PMID: 31963175. https://doi.org/10.3390/v12010109

Tsarev SA, Tsareva TS, Emerson SU, Govindarajan S, Shapiro M, Gerin JL, et al. Successful passive and active immunization of cynomolgus monkeys against hepatitis E. Proc Natl Acad Sci USA. 1994;91(21):10198–10202. PMID: 7937861. https://doi.org/10.1073/pnas.91.21.10198

Tsarev SA, Tsareva TS, Emerson SU, Govindarajan S, Shapiro M, Gerin JL, et al. Recombinant vaccine against hepatitis E: dose response and protection against heterologous challenge. Vaccine. 1997;15(17‐18):1834–1838. PMID: 9413090. https://doi.org/10.1016/s0264‐410x(97)00145‐x

Robinson RA, Burgess WH, Emerson SU, Leibowitz RS, Sosnovtseva SA, Tsarev S, et al. Structural characterization of recombinant hepatitis E virus ORF2 proteins in baculovirus‐infected insect cells. Protein Expr Purif. 1998;12(1):75–84. PMID: 9473460. https://doi.org/10.1006/prep.1997.0817

Shrestha MP, Scott RM, Joshi DM, Mammen MP, Jr, Thapa GB, Thapa N, et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med. 2007;356(9):895–903. PMID: 17329696. https://doi.org/10.1056/NEJMoa061847

Li SW, Zhang J, Li YM, Ou SH, Huang GY, He ZQ, et al. A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates. Vaccine. 2005;23(22):2893–2901. PMID: 15780738. https://doi.org/10.1016/j.vaccine.2004.11.064

Zhu FC, Zhang J, Zhang XF, Zhou C, Wang ZZ, Huang SJ, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large‐scale, randomised, double‐blind placebo‐controlled, phase 3 trial. Lancet. 2010;376(9744):895–902. PMID: 20728932. https://doi.org/10.1016/S0140‐6736(10)61030‐6

Proffitt A. First HEV vaccine approved. Nat Biotechnol. 2012;30(4):300. https://doi.org/10.1038/nbt0412‐300a

Øverbø J, Aziz A, Zaman K, Clemens J, Halle Julin C, Qadri F, et al. Immunogenicity and safety of a two‐dose regimen with hepatitis E virus vaccine in healthy adults in rural Bangladesh: a randomized, double‐blind, controlled, phase 2/pilot trial. Vaccine. 2023;41(5):1059–1066. PMID: 36599736. https://doi.org/10.1016/j.vaccine.2022.12.064

Wen J, Behloul N, Dai X, Dong C, Liang J, Zhang M, et al. Immunogenicity difference between two hepatitis E vaccines derived from genotype 1 and 4. Antivir Res. 2016;128:36–42. PMID: 26850829. https://doi.org/10.1016/j.antiviral.2016.02.002

Cao YF, Tao H, Hu YM, Shi CB, Wu X, Liang Q, et al. A phase 1 randomized open‐label clinical study to evaluate the safety and tolerability of a novel recombinant hepatitis E vaccine. Vaccine. 2017;35(37):5073–5080. PMID: 28803715. https://doi.org/10.1016/j.vaccine.2017.05.072

Li TC, Yamakawa Y, Suzuki K, Tatsumi M, Razak MA, Uchida T, et al. Expression and self‐assembly of empty virus‐like particles of hepatitis E virus. J Virol. 1997;71(10):7207–7213. PMID: 9311793. https://doi.org/10.1128/JVI.71.10.7207‐7213.1997

Niikura M, Takamura S, Kim G, Kawai S, Saijo M, Morikawa S, et al. Chimeric recombinant hepatitis E virus‐like particles as an oral vaccine vehicle presenting foreign epitopes. Virology. 2002;293(2):273–280. PMID: 11886247. https://doi.org/10.1006/viro.2001.1240

Li TC, Suzaki Y, Ami Y, Dhole TN, Miyamura T, Takeda N. Protection of cynomolgus monkeys against HEV infection by oral administration of recombinant hepatitis E virus‐like particles. Vaccine. 2004;22(3‐4):370–377. PMID: 14670318. https://doi.org/10.1016/j.vaccine.2003.08.004

Maloney BJ, Takeda N, Suzaki Y, Ami Y, Li TC, Miyamura T, et al. Challenges in creating a vaccine to prevent hepatitis E. Vaccine. 2005;23(15):1870–1874. PMID: 15734058. https://doi.org/10.1016/j.vaccine.2004.11.020

Li TC, Takeda N, Miyamura T, Matsuura Y, Wang JC, Engvall H, et al. Essential elements of the capsid protein for self‐assembly into empty virus‐like particles of hepatitis E virus. J Virol. 2005;79(20):12999–13006. PMID: 16189002. https://doi.org/10.1128/JVI.79.20.12999‐13006.2005

Wang CY, Miyazaki N, Yamashita T, Higashiura A, Nakagawa A, Li TC, et al. Crystallization and preliminary X‐ray diffraction analysis of recombinant hepatitis E virus‐like particle. Acta Crystallogr, Sect F: Struct Biol Cryst Commun. 2008;64(Pt 4):318–322. PMID: 18391436. https://doi.org/10.1107/S1744309108007197

Jariyapong P, Xing L, van Houten NE, Li TC, Weerachatyanukul W, Hsieh B, et al. Chimeric hepatitis E virus‐like particle as a carrier for oral‐delivery. Vaccine. 2013;31(2):417–424. PMID: 23107594. https://doi.org/10.1016/j.vaccine.2012.10.073

Shima R, Li TC, Sendai Y, Kataoka C, Mori Y, Abe T, et al. Production of hepatitis E virus‐like particles presenting multiple foreign epitopes by co‐infection of recombinant baculoviruses. Sci Rep. 2016;6(1):21638. PMID: 26905478. https://doi.org/10.1038/srep21638

Guo Y, Yang F, Xu X, Feng M, Liao Y, He Z, et al. Immunization of human hepatitis E viruses conferred protection against challenge by a camel hepatitis E virus. Vaccine. 2020;38(46):7316–7322. PMID: 32980200. https://doi.org/10.1016/j.vaccine.2020.09.036

Bai H, Kataoka M, Ami Y, Suzaki Y, Takeda N, Muramatsu M, et al. Immunogenicity and antigenicity of rabbit hepatitis E virus‐like particles produced by recombinant baculoviruses. Viruses. 2021;13(8):1573. PMID: 34452436. https://doi.org/10.3390/v13081573

Mallet V, Nicand E, Sultanik P, Chakvetadze C, Tessé S, Thervet E, et al. Brief communication: case reports of ribavirin treatment for chronic hepatitis E. Ann Intern Med. 2010;153(2):85–89. PMID: 20547886. https://doi.org/10.7326/0003‐4819‐153‐2‐201007200‐00257

Kamar N, Rostaing L, Abravanel F, Garrouste C, Lhomme S, Esposito L, et al. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection. Gastroenterology. 2010;139(5):1612–1618. PMID: 20708006. https://doi.org/10.1053/j.gastro.2010.08.002

Goyal R, Kumar A, Panda SK, Paul SB, Acharya SK. Ribavirin therapy for hepatitis E virus‐induced acute on chronic liver failure: a preliminary report. Antivir Ther. 2012;17(6):1091–1096. PMID: 22910532. https://doi.org/10.3851/IMP2317

Horvatits T, Schulze Zur Wiesch J, Lütgehetmann M, Lohse AW, Pischke S. The clinical perspective on hepatitis E. Viruses. 2019;11(7):617. PMID: 31284447. https://doi.org/10.3390/v11070617

Kamar N, Abravanel F, Selves J, Garrouste C, Esposito L, Lavayssière L, et al. Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis‐E virus infection after organ transplantation. Transplantation. 2010;89(3):353–360. PMID: 20145528. https://doi.org/10.1097/TP.0b013e3181c4096c

Ingiliz P, Mayr C, Obermeier M, Herbst H, Polywka S, Pischke S. Persisting hepatitis E virus infection leading to liver cirrhosis despite recovery of the immune system in an HIV‐infected patient. Clin Res Hepatol Gastroenterol. 2016;40(3):e23–e25. PMID: 2705538. https://doi.org/10.1016/j.clinre.2016.01.005

Thornton CS, Waddell BJ, Congly SE, Svishchuk J, Somayaji R, Fatovich L, et al. Porcine‐derived pancreatic enzyme replacement therapy may be linked to chronic hepatitis E virus infection in cystic fibrosis lung transplant recipients. Gut. 2024. Online ahead of print. PMID: 38621922. https://doi.org/10.1136/gutjnl‐2023‐330602

Debing Y, Gisa A, Dallmeier K, Pischke S, Bremer B, Manns M, et al. A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipients. Gastroenterology. 2014;147(5):1008.e7–1011.e7. quiz e15‐6 PMID: 25181691. https://doi.org/10.1053/j.gastro.2014.08.040

Dalton HR, Keane FE, Bendall R, Mathew J, Ijaz S. Treatment of chronic hepatitis E in a patient with HIV infection. Ann Intern Med. 2011;155(7):479–480. PMID: 21969351. https://doi.org/10.7326/0003‐4819‐155‐7‐201110040‐00017

Peters van Ton AM, Gevers TJ, Drenth JP. Antiviral therapy in chronic hepatitis E: a systematic review. J Viral Hepat. 2015;22(12):965–973. PMID: 25760481. https://doi.org/10.1111/jvh.12403

Oketani M, Ido A, Tsubouchi H. Changing etiologies and outcomes of acute liver failure: a perspective from Japan. J Gastroenterol Hepatol. 2011;26(Suppl 1):65–71. PMID: 21199516. https://doi.org/10.1111/j.1440‐1746.2010.06574.x

Fujiwara K, Yasui S, Yonemitsu Y, Mikata R, Arai M, Kanda T, et al. Efficacy of high‐dose corticosteroid in the early stage of viral acute liver failure. Hepatol Res. 2014;44(5):491–501. PMID: 23617403. https://doi.org/10.1111/hepr.12148

Fujiwara K, Hida S, Yasui S, Yokosuka O, Oda S. Corticosteroid might reduce serum levels of pro‐inflammatory cytokines in fulminant hepatitis: a case series. Hepatol Res. 2018;48(1):106–112. PMID: 28422386. https://doi.org/10.1111/hepr.12906

Yoshiba M, Inoue K, Sekiyama K, Koh I. Favorable effect of new artificial liver support on survival of patients with fulminant hepatic failure. Artif Organs. 1996;20(11):1169–1172. PMID: 8908326. https://doi.org/10.1111/j.1525‐1594.1996.tb00657.x

Yokoi T, Oda S, Shiga H, Matsuda K, Sadahiro T, Nakamura M, et al. Efficacy of high‐flow dialysate continuous hemodiafiltration in the treatment of fulminant hepatic failure. Transfus Apher Sci. 2009;40(1):61–70. PMID: 19117803. https://doi.org/10.1016/j.transci.2008.11.006

Fujiwara K, Abe R, Yasui S, Yokosuka O, Kato N, Oda S. High recovery rate of consciousness by high‐volume filtrate hemodiafiltration for fulminant hepatitis. Hepatol Res. 2019;49(2):224–231. PMID: 30277289. https://doi.org/10.1111/hepr.13255

Nakada TA, Oda S, Abe R, Hattori N. Changes in acute blood purification therapy in critical care: republication of the article published in the Japanese Journal of Artificial Organs. J Artif Organs. 2020;23(1):14–18. PMID: 31236729. https://doi.org/10.1007/s10047‐019‐01113‐7

Takikawa Y, Kakisaka K, Suzuki Y, Ido A, Shimamura T, Nishida O, et al. Multicenter study on the consciousness‐regaining effect of a newly developed artificial liver support system in acute liver failure: an on‐line continuous hemodiafiltration system. Hepatol Res. 2021;51(2):216–226. PMID: 32949102. https://doi.org/10.1111/hepr.13557

Inoue K, Oda S, Abe R, Takikawa Y, Nakayama N, Kato N, et al. Practical guide on on‐line hemodiafiltration for acute liver failure. Kanzo. 2020;61(2):47–60. (in Japanese with English abstract). https://doi.org/10.2957/kanzo.61.47

Fujiwara K, Oda S, Abe R, Yokosuka O. On‐line hemodiafiltration or high‐flow continuous hemodiafiltration is one of the most effective artificial liver support devices for acute liver failure in Japan. J Hepatobiliary Pancreat Sci. 2015;22(3):246–247. PMID: 25565563. https://doi.org/10.1002/jhbp.204

Ushiro‐Lumb I, Forsythe J, Haywood B, Geoghegan C, Maddox V, Ijaz S, et al. Impact of hepatitis E virus screening in the UK deceased organ donor population. Transpl Int. 2023;36:11673. PMID: 37727381. https://doi.org/10.3389/ti.2023.11673

Nishiyama T, Kobayashi T, Jirintai S, Kii I, Nagashima S, Prathiwi Primadharsini P, et al. Screening of novel drugs for inhibiting hepatitis E virus replication. J Virol Methods. 2019;270:1–11. PMID: 31004661. https://doi.org/10.1016/j.jviromet.2019.04.017

Murata K, Kang JH, Nagashima S, Matsui T, Karino Y, Yamamoto Y, et al. IFN‐λ3 as a host immune response in acute hepatitis E virus infection. Cytokine. 2020;125:154816. PMID: 31465972. https://doi.org/10.1016/j.cyto.2019.154816

Nishiyama T, Kobayashi T, Jirintai S, Nagashima S, Primadharsini PP, Nishizawa T, et al. Antiviral candidates against the hepatitis E virus (HEV) and their combinations inhibit HEV growth in in vitro. Antivir Res. 2019;170:104570. PMID: 31362004. https://doi.org/10.1016/j.antiviral.2019.104570

Primadharsini PP, Nagashima S, Nishiyama T, Takahashi M, Murata K, Okamoto H. Development of recombinant infectious hepatitis E virus harboring the nanoKAZ gene and its application in drug screening. J Virol. 2022;96(6):e0190621. PMID: 35107380. https://doi.org/10.1128/jvi.01906‐21

Nagashima S, Primadharsini PP, Nishiyama T, Takahashi M, Murata K, Okamoto H. Development of a HiBiT‐tagged reporter hepatitis E virus and its utility as an antiviral drug screening platform. J Virol. 2023;97(9):e0050823. PMID: 37681960. https://doi.org/10.1128/jvi.00508‐23

Maeda N, Horochi S, Hasegawa Y, Iwasaki T, Nakatani N, Miyasho T, et al. Decreased immunoreactivity of hepatitis E virus antigen following treatment with sakhalin spruce (picea glehnii) essential oil. Chem Biodivers. 2023;20(4):e202200924. PMID: 36929088. https://doi.org/10.1002/cbdv.202200924

Li TC, Wakita T. Small animal models of hepatitis E virus infection. Cold Spring Harb Perspect Med. 2019;9(8):a032581. PMID: 29735581. https://doi.org/10.1101/cshperspect.a032581

Zhang W, Ami Y, Suzaki Y, Doan YH, Jirintai S, Takahashi M, et al. Persistent infection with a rabbit hepatitis E virus created by a reverse genetics system. Transbound Emerg Dis. 2021;68(2):615–625. PMID: 32649803. https://doi.org/10.1111/tbed.13723

Primadharsini PP, Nagashima S, Tanaka T, Jirintai S, Takahashi M, Murata K, et al. Development and characterization of efficient cell culture systems for genotype 1 hepatitis E virus and its infectious cDNA clone. Viruses. 2023;15(4):845. PMID: 37112827. https://doi.org/10.3390/v15040845

Ianiro G, Monini M, De Sabato L, Chelli E, Cerini N, Ostanello F, et al. Dynamic of hepatitis E virus (HEV) shedding in pigs. Animals (Basel). 2022;12(9):1063. PMID: 35565491. https://doi.org/10.3390/ani12091063

Saadat A, Gouttenoire J, Ripellino P, Semela D, Amar S, Frey BM, et al. Inborn errors of type I interferon immunity in patients with symptomatic acute hepatitis E. Hepatology. 2023;8(6):1421–1431. Online ahead of print. PMID: 38079352. https://doi.org/10.1097/HEP.0000000000000701

Oechslin N, Da Silva N, Ankavay M, Moradpour D, Gouttenoire J. A genome‐wide CRISPR/Cas9 screen identifies a role for Rab5A and early endosomes in hepatitis E virus replication. Proc Natl Acad Sci USA. 2023;120(52):e2307423120. PMID: 38109552. https://doi.org/10.1073/pnas.2307423120

Recent advances in hepatitis E virus research and the Japanese clinical practice guidelines for hepatitis E virus infection.

Journal

Informations de publication

Résumé

Identifiants

Types de publication

Langues

Subventions

Investigateurs

Informations de copyright

Références

Auteurs

Tatsuo Kanda (T)

Tian-Cheng Li (TC)

Masaharu Takahashi (M)

Shigeo Nagashima (S)

Putu Prathiwi Primadharsini (PP)

Satoshi Kunita (S)

Reina Sasaki-Tanaka (R)

Jun Inoue (J)

Atsunori Tsuchiya (A)

Shingo Nakamoto (S)

Ryuzo Abe (R)

Keiichi Fujiwara (K)

Osamu Yokosuka (O)

Ryosuke Suzuki (R)

Koji Ishii (K)

Hiroshi Yotsuyanagi (H)

Hiroaki Okamoto (H)

Classifications MeSH